key: cord-0025003-0o5ai39k
authors: nan
title: 2021 ACVIM Forum Research Abstract Program
date: 2021-08-05
journal: J Vet Intern Med
DOI: 10.1111/jvim.16220
sha: 24d9f1c5b7b1515459474a06c81a073c39b7da8d
doc_id: 25003
cord_uid: 0o5ai39k

nan

In conclusion, no benefits of pre-operative atenolol treatment were identified in dogs undergoing pulmonic balloon valvuloplasty or stenting. (LVIDDN) and left atrium to aortic ration (LA:Ao)) was tested using multivariable linear regression analysis adjusting for sex and age.

There was no significant difference in LVIDD, LVIDDN We found no overall association between MMVD and SM. Dogs affected with symptomatic SM had less severe MMVD compared to dogs with asymptomatic SM indicating it is important to be aware of both diseases when breeding CKCS.

Differentiating preclinical myxomatous mitral valve disease stages using electrocardiography in Cavalier King Charles spaniels the study, a 30-second resting right lateral six-lead ECG was performed and analyzed off-line using IDEXX CardioPet. Measured variables included; P wave duration (ms), P wave amplitude (mV), PR interval (ms), R wave peak time (ms), QRS duration (ms), R wave amplitude (mV), QT interval (ms). Twenty sequential RR intervals were used to calculate average heart rate (HR) and vasovagal tonus index (VVTI) to assess HRV.

Additionally, QRS+P duration (ms), a novel ECG variable, was calculated.

Receiver operating characteristic (ROC) curves were constructed for each variable to determine their discriminatory utility. The area under the curve (AUC) was < 0.6 for P and R amplitude, PR and QT interval, R wave peak time, HR and VVTI, demonstrating poor discrimination.

The AUC for P and QRS duration was 0.742 and 0.759 respectively, demonstrating fair discrimination. The AUC for QRS+P duration was 0.812 (standard error = 0.037; 95% confidence interval = 0.750 -0.884; p < 0.0001), demonstrating good discrimination. A cut-off of 79 ms for QRS+P duration had good specificity (85%) and fair sensitivity (59%) for identification of Stage B2, suggesting it may be useful to rule-out Stage B2 in CKCS with preclinical MMVD with a false negative rate of 10%. However, the false positive rate remains high at 51%. Subsequent decision tree analysis using P (< 40 ms) and QRS (< 39 ms) in series reduced the false negative rate to 6% but the false positive rate remained high at 42%.

These data suggest that P and QRS durations combined as P+QRS or in series may represent a good screening test to rule-out Stage B2 MMVD in CKCS with preclinical MMVD with a negative predictive value 90-94%.

Interaction of transforming growth factor-beta and serotonin induced mouse valvulopathy model: A pilot study Bedoya Nadar, Gianninne 1 , Hogan, Daniel F. 2 Administration of high levels of serotonin to rats results in valve lesions similar to carcinoid heart disease and administration of serotonergic drugs. We propose that TGF-β signaling functions in an overseer role, regulating multiple other tissue pathways, including serotonin in which impaired TGF-β function results in dysregulated tissue growth. We hypothesize that the morphologic valvular changes induced by ALK5 antagonism will be reduced or prevented by the administration of the serotonin antagonist cyproheptadine. Twenty-two mice were used for this study; 5 negative controls (Group A), 10 received the ALK5 antagonist AZ12799734 (Group B), and 7 received cyproheptadine and AZ12799734 (Group C). After seven days of AZ12799734, the hearts were collected for histologic analysis. Valve morphology was evaluated using a semi-quantitative scoring system, fibrosis was assessed using

Masson's Trichrome, and IHC was used to quantify alpha-smooth muscle actin (SMA). Administration of AZ12799734 induced morphologic changes in all mice and were notably different from the control group.

While there was a significant expansion in the spongiosa and an increase in interstitial cells in Group B compared to control (p=0.005), this was not true for Group C (p=0.072); total valve score was also not significantly different between Groups A and B (p=0.064), Groups A and C (p=0.078), or Groups B and C (p=1.00). There was no significant difference in fibrosis or SMA between any groups.

The administration of the ALK5 antagonist AZ12799734 to mice resulted in morphologic changes to the valves although this pilot study was underpowered. The administration of the serotonin antagonist cyproheptadine did not prevent these changes. We conclude that 1) serotonin is not a key element in this valvulopathy model 2) alterations in the TGF-β pathway likely play a key role in MMVD, and 3) these results further add to the complexity of this important disease process.

Main pulmonary artery end-diastolic forward flow (EDFF) has been studied in humans with repaired tetralogy of Fallot as a potential indicator of restrictive right ventricular physiology (r-RVP). We sought to evaluate EDFF in dogs with two other conditions characterized by r-RVPpulmonic stenosis (PS) and precapillary pulmonary hypertension (PH). We proposed that individuals in these disease groups have increased EDFF magnitude compared to dogs with structurally and functionally normal hearts, and that increasing EDFF maximum velocity in these patients is associated with more severe right ventricular (RV)

hypertrophy. Retrospective analysis of echocardiographic studies of 50 PS patients, 50 PH patients, and 12 (6 age and weight matched individuals for each disease group) normal dogs evaluated by the University of Tennessee Veterinary Medical Center Cardiology service between Table 1 . Mann-Whitney U nonparametric test assessing the differences between maximum EDFF velocity in the pulmonary hypertension and pulmonic stenosis disease groups and the maximum EDFF velocity in their respective age and weight-matched normal groups Myxomatous mitral valve disease (MMVD) is one of the causes of congestive heart failure (CHF) in small-breed dogs. Based on our clinical observations, few dogs with CHF secondary to MMVD are stable to the extent that the dose of diuretic can be lowered, tapered, or stopped. Therefore, this study aimed to investigate the differences between dogs with MMVD that showed resolution of CHF and those that died due to cardiac causes.

Electronic Iams (2.1%); the rest of the patients were either switched to a non-WSAVA diet or no data was available (10.4% and 6.3%, respectively).

Taurine was prescribed to 49 patients in the analysis (96%) and pimobendan was used in 30 dogs (58.8%). Ten patients were presented in congestive heart failure (19.6%) and treated with pimobendan, furosemide, and an ACE-inhibitor (enalapril or benazepril). Only 1 patient from that pool did not improve due to presumed concurrent idiopathic DCM.

In conclusion, the majority of dogs who were presented for evaluation improved with at least a diet change. This data solidifies the potential for improvement with a diet change and taurine supplementation, as well as an improvement in function with proper congestive heart failure treatment. ng/mL, P = 0.002). Plasma galectin-3 levels increased significantly with increasing heart rate and body weight (R 2 = 0.273, P = 0.003).

However, other cardiac biomarkers, inflammatory cytokines, and echocardiographic parameters were not significantly associated with galectin-3 expression. In logistic regression analysis, galectin-3 and age were considered suitable for the detection of MMVD (predictive accuracy = 90.0%, P < 0.05).

In conclusion, concentrations of plasma galectin-3 were higher in dogs with MMVD compared to healthy dogs, especially in dogs with higher MMVD severity. In addition, the results suggest that galectin-3 is sufficiently useful to screen for MMVD and is a novel cardiac biomarker in dogs with MMVD. Further research is required to investigate the changes in plasma galectin-3 levels during long-term follow-up and its role in determining the prognosis of dogs with MMVD. show that ccfDNA has increased with the stage overall. Especially, ccfDNA has increased dramatically between stage B1 and stage B2

(P < 0.01) which has strong recommendation for initiation of Pimobendan. The result of this study may suggest that apoptosis or necrosis occurs in LHF due to MMVD and that the level of ccfDNA increases due to the active modulation of the heart from stage B2.

In veterinary medicine, the understanding of the interaction between renal and cardiovascular system is increasing, but it has not yet been completely elucidated. Therefore, in this study, we aimed to investigate the cardiorenal system in dogs by evaluating chronic kidney disease (CKD) as a risk factor for the progression of myxomatous mitral valve disease (MMVD).

The medical records of 63 dogs diagnosed with MMVD stage B1, B2, or C, according to the guidelines of the American College of Veterinary

Internal Medicine, were retrospectively reviewed. The progression of MMVD was examined 6 months after the first diagnosis, and the mortality rate was recorded. The indicators for the progression of MMVD and mortality rate were compared between the dogs with only MMVD (MMVD group) and the dogs with both CKD and MMVD (concurrent group).

In MMVD stages B2 and C, change in vertebral heart score was significantly greater in the concurrent group than in the MMVD group (P < 0.01 and P = 0.02, respectively). In all stages of MMVD, the concurrent group showed a greater change in left ventricular enddiastolic diameter normalized for body weight than the MMVD group (P < 0.05). However, no significant differences were found in the progression of murmur grade and left atrium/aorta ratio between the two groups (P > 0.05). The mortality of the concurrent group was significantly higher than that of the MMVD group (P < 0.01).

These results provide an insight into the relationship between CKD and MMVD, and suggest the potential role of CKD as a risk factor for the progression of canine MMVD. Orthostatic hypotension (OH), defined as systolic blood pressure (SBP) decrease of ≥20 mmHg, is frequently observed in elderly people who feel fainting on rapid rising. An old Maltese Terrier presented for syncope while being brought up quickly from the ground by her owner. The simulated manipulation reduced the dog's SBP, and this raised a question of whether OH could be induced by rapid altitude raise (RAR), which is a common daily situation in the lives of toy breeds. The purpose of this study was to prospectively investigate the SBP change by RAR test in geriatric toy-breed dogs.

Twenty-five client-owned dogs >8 years old with a body height of < 50 cm were included. Dogs were excluded if critically ill, uncooperative, or having baseline SBP < 100 mmHg. Baseline SBP was measured by Doppler sphygmomanometry, and measurements were immediately repeated during the subsequent 180 seconds after the dog was quickly lifted in a 2-leg standing posture up from the ground to a height of approximately 120-130 cm.

The average SBP after RAR test decreased by ≥20 (defined as OH)

and 10-20 mmHg (suspected OH) relative to the baseline SBP in 8%

(-29.6 ± 6.2 mmHg) and 28% (-15.0 ± 2.9 mmHg) of the dogs, respectively. None of these dogs experienced syncope or weakness.

Age, gender, severity of heart disease, and current antihypertensive medication did not statistically affect the SBP drop.

In conclusion, OH can occur after RAR in geriatric toy-breed dogs, but it is uncommon to induce clinical signs.

Increased N-terminal pro-B-type natriuretic peptide is associated with increasing concentrations of renal biomarkers over time measurements the 24-month study period started with that measurement. Dogs were only included if they were breeds classified as "small"

or "toy" breeds by the American Kennel Club and not Italian Greyhounds or Cavalier King Charles Spaniels. Animals were weighted by boosted logistic regression models to balance patient characteristics between the three groups. Increased SDMA and Cr were. SDMA was more commonly increased than Cr: increased SDMA ( >14mg/dL) was found in < 25% of dogs and approximately 33% of cats. Dogs with increased NT-proBNP had significantly higher mean SDMA and Cr at time of NT-proBNP testing (p < 0.001) than did dogs in comparison groups. Additionally, dogs and cats with increased NT-proBNP had greater increases in mean SDMA and Cr concentrations over the 24-month trending period (all p < 0.001) than comparison groups.

These data indicate there is a relationship between increased NT-proBNP and SDMA/Cr in this large population and that patients with increased NT-proBNP may be at higher risk of declining renal excretory function. While NT-proBNP can be increased in patients with decreased renal excretory function, most patients were not azotemic when NT-proBNP was measured. Further study into the relationship between these markers and into the ability of these markers to predict or identify patients at risk for cardiorenal disease is needed.

Prevalence of pacemaker-lead-induced thrombosis in dogs diagnosed on echocardiography following transvenous cardiac pacing The half-life (T½) of elimination was approximately 1, and 1.4 hours for pimobendan and the metabolite, respectively. The T½ was highly variable for pimobendan with a coefficient of variation of 59.1% compared to 11.9% for the metabolite. The peak concentration was 32.7 and 29.3 ng/mL, for pimobendan and the metabolite, respectively. The areaunder-the-curve and peak concentration were similar for pimobendan and the metabolite with ratios of 1.1 and 0.9, respectively.

Although the concentrations and pharmacokinetic parameters were highly variable among dogs, the stage of MMVD (B2, C, D) was not a significant source of variability in the parameters. Additional covariates will be explored to determine if they contribute to the source of variability which may lead to a better understanding of optimal pimobendan dosing in the management of canine MMVD. Our findings suggest that low body weight is a useful predictor of postoperative hypoglycemia. Unexpectedly, low insulin and high glucagon concentrations were observed in dogs with hypoglycemia. Cardiopulmonary bypass and/or mitral surgery may affect glucose metabolism in dogs with low body weight.

can share the same phenotypical markers of myocardial hypertrophy.

At a certain stage, it could be a problem in the differentiation of primary and secondary hypertrophy. In this study, we analyze the clinical utility of muscle-associated miR1, miR133, and miR208 and fibrosisassociated miR21 and miR223 as circulating biomarkers of myocardial hypertrophy.

This study included 46 cats, divided into 3 groups: control healthy cats without markers of myocardial hypertrophy (HC, n=20); cats with diagnosed hypertrophic cardiomyopathy (HCM, n=11); cats with the markers of myocardial hypertrophy secondary to chronic renal disease (CKD, n=15). Diagnostic criteria included: clinical signs, arterial pressure measurements, echocardiography, electrocardiography, clinical and biochemical blood analyses, serum Troponin I evaluation. Plasma samples we obtained for miRNA analysis and ribonuclease activity evaluation. Levels of circulating in plasma miR1, miR21, miR133, miR208, and miR223 were analyzed by RT-qPCR. Ribonuclease activity in plasma was evaluated by analysis of the degradation of spiked-in exogenous RNA.

The nonparametric Mann-Whitney test was used to compare the quantification cycle (Cq) between two groups. Two-sided P values less than 0.05 were considered statistically significant. GraphPad Prism 8.00 (GraphPad Software Inc., La Jolla, CA, USA) was used to perform statistical analysis and visualizations. Differences between groups were deemed statistically significant if p-value < 0.05. The relative levels of gene expression (RQ) in each sample were calculated as RQ = 2^(Cq max -Cq sample).

In the CKD group, a significant decrease of miR1 level and an increase of miR223 level ( P < 0.01, for both) in comparison to healthy cats were observed. Levels of miR1, miR21, miR133, miR208, miR223 remain unchanged between groups of primary and secondary myocardial hypertrophy. Ribonuclease activity of plasma in cats with CKD was more than 10 times higher (P < 0.01) compared to both healthy cats and cats with HCM. There was no difference in plasma ribonuclease activity between HCM and healthy cats.

Investigated muscle-and fibrosis-associated miRs cannot be used as plasma biomarkers to differentiate primary and secondary myocardial hypertrophy. CKD was shown to be associated with increased plasma ribonuclease activity. However, changes in plasma ribonuclease activity are unlikely to affect circulating plasma miRs levels, since mature miRs are believed to be protected from degradation by protein complexes. 

Prognostic value of left ventricular-arterial coupling estimated using echocardiography in canine myxomatous mitral valve disease (Ees) ratio (Ea/Ees). The Ea is an index of total arterial load of LV, while Ees is an index of LV systolic function. A recent study found that inappropriate VAC based on increased Ea/Ees estimated using echocardiography is associated with advanced disease severity in dogs with myxomatous mitral valve disease (MMVD). This prospective cohort study investigated the prognostic value of VAC assessed by echocardiographic estimation of Ea/Ees in dogs with MMVD.

Eighty-nine dogs with MMVD underwent baseline echocardiographic examinations. The Ea was echocardiographically estimated using the formula: mean blood pressure/(forward stroke volume/body weight).

The Ees was echocardiographically estimated using the formula: mean blood pressure/(LV end-systolic volume/body weight). The Ea/Ees was then calculated. A prospective questionnaire-based study was used to evaluate owners' medication adherence for management of cardiovascular disease in the small animal specialty setting. Owners completed a written survey evaluating medication adherence, and difficulties encountered for medication adherence. Owners were free to decline participation in the study. One hundred questionnaires were completed during a 3-month period at a small animal specialty hospital.

Fifty-seven respondents (57%) reported treating their pet for over a year for cardiovascular disease and myxomatous mitral valve disease was the most common diagnosis (73%). Thirty-one respondents felt they could consistently administer at most 3 medications daily and 50 respondents reported twice daily dosing was the highest frequency of medications they could consistently administer. Twenty-four respondents (24%) reported their pet required daily medications for at least one other condition besides cardiac disease. Twenty-one Forty client-owned dogs with confirmed congenital heart disease were enrolled. Thirty dogs weighing > 4kg had TEE performed with a 6VT-D probe (GE) and 10 dogs < 4kg had TEE performed with two probes in sequence; a 10T-D microprobe (GE) followed by an intracardiac echocardiography catheter-based probe. Direct visualization of the oropharyngeal region and esophagus by endoscopy was performed before and immediately after each TEE study to score gross changes to esophageal mucosa.

The times for probe within the esophagus, active imaging, and imaging in three-dimensions were recorded. Following anesthetic recovery, dogs were monitored for signs of nausea until the morning after TEE. Texas A&M University, Bryan, Texas, USA Patient size is a limiting factor for transesophageal echocardiography (TEE) probe placement and image acquisition for interventional management of canine heart disease. The objective of this study was to evaluate the GE 10T-D microprobe and intracardiac echocardiography (ICE) catheter-based probe for TEE in small dogs to describe and compare imaging capabilities, ease of use, and image quality.

Ten client-owned dogs of various breeds weighing < 4kg with confirmed congenital heart disease were prospectively enrolled. Each dog had TEE performed with both probes in alternating order. The ease of probe placement, ability to acquire specific diagnostic images including region of interest, and image quality were recorded for each probe.

Median weight was 2.4kg (range, 1.0-3.2). Congenital abnormalities included patent ductus arteriosus (n=9) and pulmonic stenosis (n=1).

The 10T-D microprobe has anteflexion and retroflexion capabilities but lacks lateral motion and was not difficult (easy, n=8) to mildly difficult (achievable with manipulation, n=2) to place. A complete imaging study (8/10) and images of the defect of interest (9/10) was possible. Diagnostic image quality was scored good (3/10) to excellent (7/10). The ICE probe was difficult to place without external support, was difficult to operate, and was rarely able to acquire a full sequence of standardized diagnostic images.

While the ICE catheter-based probe was not useful as a TEE probe, the 10T-D microprobe was able to provide good to excellent image quality in the majority of dogs < 4kg; however, the lack of lateral motion of the probe head can diminish its utility in some dogs.

Presence of previous left atrial rupture scar in dogs undergoing mitral valve repair surgery include alterations in the extracellular matrix (ECM) and collagen, possibly as a result of the activation of matrix metalloproteinases (MMPs), leading to subsequent myocardial re-modeling. Inflammatory cytokines are also hypothesized to influence progression of the valve lesion contributing to valvular regurgitation. We assessed the circulating levels of miRNAs using Qiagen's miScript miRNA PCR array Dog Cardiovascular Disease, in the blood of dogs collected at the end-oflife. Data were analyzed using the DDCt method. In this retrospective study, five dogs had been clinically diagnosed as having at least grade 3 heart murmur when alive (2 dogs had grade 5/6, 2 had 4/6 and 1 had 3/6 heart murmur) and most were diagnosed as having MVD by a veterinarian. RNA was extracted from blood samples collected at the end-of-life from dogs with heart murmurs (n=5; 12.8-14.9 yr) and control dogs (n=6; 13.3-14.6 yr) with no known history of cardiovascular problems. There was a significant up-regulation in the levels of miRNAs cfa-miR-222 and cfa-miR-365 in dogs with heart disorders when compared to controls (p < 0.05). miR-222 has been demonstrated to inhibit TIMP-2 and TIMP-3, natural inhibitors of matrix metalloproteinases (MMPs), enabling MMPs to be up-regulated and act on ECM proteins. MMP-2, a target of TMP-2, plays an important role in the progression of MVD. In addition, miR-365 also negatively regulates TIMP-1 and TIMP-3, and TIMP3 reduction leads to poor cardiac remodeling. Other miRNAs that were also upregulated (> 2-fold increase) when compared to controls include miR-7, miR-18a, miR-19a, miR-21, miR-23a, miR-26a, miR-27a, miR-27b, miR-29a, miR-29b, miR-29c, miR-30e, miR-99a, miR-218, miR-223, and miR-499 (NS vs Con). In contrast, cfa-miR-494 was significantly down-regulated in dogs with cardiovascular problems when compared to controls (p < 0.05). Decreased levels of miR-494 can increase cytokine expression and inflammation, as reported in a macrophage cell line. In addition, cfa-miR-143 was also downregulated compared to controls (NS) and targets of miR-143 include tropomyosin-4 (TPM-4), a structural protein, and angiotensinconverting enzyme (ACE), a major regulator of contraction, and thus, a decreased level of mir-143 may contribute to heart dysfunction.

Taken together, these results suggest that circulating miRNAs may serve as clinical biomarkers in dogs with cardiovascular valve disorders as well as in assessing its progression, and possibly as targets for nutritional intervention.

The efficacy of isosorbide dinitrate in the treatment of congestive heart failure: A pilot study Wiley, Lauren E. 1 , Trafny, Dennis 2 , White, Andrew M. 3 1 BluePearl Veterinary Partners, New York City, New York, New York, USA, 2 self-employed, New York, NY, New York, USA, 3 Garden State Veterinary Specialists, New Providence, USA Preload reducers (i.e., nitroprusside) have been used to treat dogs with degenerative mitral valve disease (DMVD) in congestive heart failure (CHF) with anecdotal success. Now that nitroprusside is cost prohibitive in most cases, alternative preload reducers warrant exploration.

Isosorbide dinitrate is a preload reducer for which pharmaco-kinetic and -dynamic research has been performed in dogs. The purpose of this study is to determine if the use of the preload reducer, isosorbide dinitrate, will improve heart failure more rapidly without significantly lowering blood pressure in patients with CHF in a prospective, randomized, double-blinded, placebo-controlled clinical trial. DMVD dogs in their first episode of CHF and requiring hospitalization were enrolled.

Study dogs were randomized into a placebo group (n = 10) or a preload reducer group (n = 7) in which patients received isosorbide dinitrate 5-7 mg/kg PO q12. The outcome parameters time in oxygen and hospital, indirect blood pressure, fraction of inspired oxygen (FiO2), and total furosemide administered were measured at 0, 6, 12, and 24 hours of hospitalization. Creatinine and BUN were measured at admission and discharge (defined by time animals were weaned out of an oxygen cage). Data were statistically evaluated using standard paired t-tests at the time points (significance set at P < 0.05). No statistical difference in baseline characteristics was seen between the groups. There was no statistical difference in furosemide administration at presentation, or at the time points of 6, 12, 24 or mg/kg/day at time of discharge between the placebo and preload-reducing groups. No statistical difference was found in respiratory rate, blood pressure, BUN, creatinine or time to discharge between placebo and preload-reducing groups. While the blood pressure and respiratory rates initially decreased in the preloadreducing group compared to the placebo group, statistical significance was not met. Isosorbide dinitrate did not significantly decrease blood pressure throughout hospitalization. The use of isosorbide did not more rapidly improve heart failure morbidity in DMVD patients with first time CHF.

Influence of heart rate on right ventricular function in healthy dogs Eight healthy anesthetized beagles were enrolled in this study.

Right heart catheterization and echocardiography were performed at each right atrial pacing rate (baseline, 120, 140, 160, 180 bpm). Maximum and minimum RV pressure, volume and first derivative of RV pressure (dP/dt) were measured using RV pressure-volume loop. End-systolic elastance (Ees) was calculated using single beat method. Normalized tricuspid annular plane systolic excursion (TAPSEn), normalized RV fractional area change (RV FACn), and myocardial systolic velocity of lateral tricuspid annulus (RV s') were measured for RV systolic function. Only RV free wall and RV global (6seg) strain and strain rate (RV-SrL) were measured using two-dimensional speckle tracking echocardiography.

There was no significant change in RV pressure, minimum dP/dt, RVs', RV strain, and RV-SrL 3seg among each HR. With the increase of HR, RV volume and TAPSEn decreased (all were P < 0.01), and maximum dP/dt and Ees increased (both were P < 0.05). Multiple regression analysis showed that RV-SrL 6seg , RV FACn, and HR were significantly associated with Ees (all were P < 0.05).

Results of RV volume may reflect the decreased venous return due to increased HR. However, RV contractility evaluated by Ees and maximum dP/dt was increased reflecting the force-frequency relationship.

The RV-SrL 6seg and RV FACn might be useful tools to evaluate RV contractility.

Myocardial function assessed by two-dimensional speckle-tracking echocardiography in cats with cardiomyopathy and congestive heart failure In two miniature donkeys with symptomatic AV block, a rateadaptive single chamber pacemaker with accelerometer, CLS and remote monitoring functionality (Eluna 8 SR-T, Biotronik) was implanted. A bipolar steroid eluting screw-in lead in the right ventricular apex was connected to the pacemaker. After full recovery, rate-adaptivity was assessed. In contrast to periods where no physical activity was present, during low-level exercise, increases in heart rate could be obtained with both the accelerometer and CLS function. During periods of stress, without any physical activity, only the CLS function produced physiological heart rates. With a receiver nearby the donkey (< 4m distance), successful wireless remote monitoring was obtained in both cases with exchange of data to the clinician. CLS functionality successfully allowed to achieve physiologicallypaced heart rate adaptation in relation to actual needs. It also resulted in rate response without physical motion. Remote monitoring allowed automatic reporting of pacemaker function which facilitate follow-up.

Renin-angiotensin-aldosterone system profiling in horses before and after exercise (ACE) cleaves angiotensin I to angiotensin II to cause vasoconstriction, sodium retention, and inflammation. Its homologue, ACE2, regulates the counter-regulatory RAAS pathway by degrading angiotensin II to angiotensin 1-7, which causes vasodilation, natiuresis, and anti-inflammation. The RAAS is implicated in pulmonary disease and ACE2 protects against lung injury in people. Evaluation of the effect of exercise on the RAAS in horses is necessary before investigating whether dysregulation occurs in diseases such as exercise-induced pulmonary hemorrhage. We hypothesized that exercise would activate the RAAS and ACE2 would be detectable in horses.

The RAAS was evaluated in serum samples from 25 healthy horses before and immediately after exercise using equilibrium analysis (4 Thoroughbreds, treadmill-exercise [TB-TM]; 10 Arabians, 50-mile endurance ride; 5 Thoroughbreds, 1 mile race [TB-R];

6 Quarter Horses-race 250-500 yards [QH-R]). Exercise increased angiotensins I, II, 1-5, 1-7, aldosterone, renin activity, and ACE2

(P< .001 all) and decreased aldosterone:angiotensin II (P = 0.002).

The concentration of ACE2 (P< 0.001) but not neutral endopeptidase (P = 0.5) increased after exercise indicating that ACE2 mediated the conversion of angiotensin II to angiotensin I-7. TB-R had higher post-exercise angiotensin II, renin activity, and % change ACE2 than TB-TM (adjusted P = 0.03). TB-R and QH-R had higher post-exercise angiotensin 1-5 than TB-TM (adjusted P < 0.03).

Exercise activates the RAAS in healthy horses, with prominent ACE2-mediated conversion of angiotensin II to angiotensin 1-7 and greater activation in TB-R compared to TB-TM.

Atrial fibrillatory rate as predictor of recurrence of atrial fibrillation in horses surface ECG is considered a biomarker for electrical remodeling and could potentially be used for prediction of AF recurrence after cardioversion. This retrospective multicenter study evaluated if AFR could predict AF recurrence in horses.

Horses with persistent AF admitted for cardioversion with either medical treatment (quinidine) or transvenous electrical cardioversion (TVEC) were included and AFR was calculated from the surface ECGs. In conclusion, high AFR was associated with failure of quinidine cardioversion as well as AF recurrence after successful TVEC. As a noninvasive marker retrieved from surface ECG, AFR can be clinically useful in predicting the probability of maintaining SR after electrical cardioversion and identification of non-responders subjected to quinidine treatment.

Utility of a modified wearable ECG patch for 7-day monitoring in horses Durward-Akhurst, Sian A. 1 , Blanchard, Kendall 2 , Loly, Sue 2 , Hauser, Robert G. 3 The FDA-approved Cardea SOLO enables non-invasive ECG monitoring in people for up to 7 days. We modified the device's wearable adhesive patch ECG monitor to record a single ECG lead with one electrode behind the right elbow and the second on the left behind the proximal scapula to allow convenient ECG monitoring of horses.

After 7 days the ECG recordings were analyzed by proprietary computer software. For the first and last 24 hours, a Televet was placed to allow comparison between ECG traces.

The modified SOLO was well-tolerated by all 15 sedentary mixed breed horses (14 mares, 1 stallion). During an average ±SD 6.5±1.1 days of monitoring, the mean ±SD heart rate was 40±4 beats/minute. Brief episodes of bradycardia and second-degree atrioventricular block were common in all subjects. Two horses had one or more episodes of paroxysmal supraventricular tachycardia and one horse had 3 episodes of brief non-sustained ventricular tachycardia (fastest rate 141 bpm for 10.6 seconds). Atrial fibrillation was not observed. Overall, the SOLO recordings correlated well with those obtained with Televet.

These results suggest that the modified Cardea SOLO monitor is an accurate and practical long-term ECG recording method for detecting paroxysmal arrhythmias in horses.

Repeatability of heart rate variability measurements during standardized treadmill exercise test in thoroughbred horses Tanquerel, Ludovic A. 1 

Equine de Maisons-Alfort, Maisons-Alfort, Ile-de-France, France

Heart Rate Variability (HRV) is increasingly used in equine sport medicine to detect arrhythmias during exercise. Although cut-offs of HRV parameters have been calculated between normal HRV and abnormal arrhythmias, repeatability of HRV has not been evaluated.

The objective was to evaluate if HRV parameters measurements (mean RR intervals, mean heart rate, standard deviation of RR intervals (SDRR), triangular index (TI), triangular index triangular interpolation of RR intervals (TIRR), square root of mean squared differences between successive RR intervals (RMSSD), %RR deviation) are repeatable during Standardized Treadmill Exercise Test (STET).

Five healthy Thoroughbred mares with normal ECG at rest (mean age HRV parameters measurements appear to be repeatable during standard exercise treadmill. Main limitations: limited number of horses.

The insulin-modified frequently sampled intravenous glucose tolerance test in healthy neonatal foals and horses (p < 0.0001). AIRg and Sg were not significantly different between foals and horses. While the acute insulin response to glucose (AIRg) and ability of glucose to mediate its own disposal (Sg) were not different between foals and horses, insulin had a higher capacity to promote glucose disposal and inhibit endogenous glucose production (SI) in foals versus adults. These results suggest that healthy neonatal foals may not be insulin resistant, but insulin sensitive, and this could be an adaptation to conserve energy in the transition to extrauterine life. 

Cortisol and adrenocorticotropin (ACTH) response to corticotropinreleasing-hormone (CRH) stimulation tests in healthy and hospitalized foals on CRH stimulation tests in foals is lacking.

The purpose was to evaluate the response of cortisol and ACTH to different doses of CRH in foals. We hypothesized that, cortisol and ACTH will increase in response to exogenous CRH in healthy and hospitalized foals, and there will be a dose dependent effect. CRH (0.1, 0.3, and 1μg/kg) was administered intravenously to healthy and hospitalized foals < 7 days of age. Blood samples were collected before and 15, 30, 60, and 90 minutes after administration of CRH for determination of plasma ACTH and cortisol concentrations.

In healthy foals, cortisol concentrations increased at 15 minutes from baseline with 0.1 and 0.3μg/kg and at 30 and 60 minutes from baseline with 1μg/kg CRH (P < 0.05). The delta cortisol (0-30min, 0-60min) and ACTH (0-30min, 0-60min) was higher for the 1μg/kg compared with the 0.1μg/kg CRH (P < 0.05). In the hospitalized foals, cortisol and ACTH concentrations increased at 15 minutes from baseline with the 0.1μg/kg of CRH and ACTH concentrations increased from baseline at 30 minutes with 1μg/kg (P < 0.05). The delta ACTH 0-15min was higher for the 1μg/kg compared to the 0.1μg/kg (P < 0.05). There was no difference in cortisol and ACTH response to CRH between healthy and hospitalized foals.

The results suggested, cortisol and ACTH increased in response to administration of all 3 doses of CRH, and 1μg/kg dose of CRH is optimal for HPAA assessment in healthy and hospitalized foals.

Comparison of proxies of insulin sensitivity and insulin secretion between foals and adult horses Kinsella, Hannah M. 1 , Hostnik, Laura D. 2 

The effect of transferring equine plasma into silicate-containing tubes to improve short-term ACTH stability Pituitary pars intermedia dysfunction (PPID) is a common endocrinopathy affecting approximately 20% of horses ≥ 15 years. PPID is confirmed by increased plasma ACTH concentrations; however, ACTH has a poor stability due to proteolytic degradation and possible interaction with blood cells. It is advised to collect blood into EDTA tubes and transfer plasma into cryovials after centrifugation for transportation to laboratories. However, in clinical practice cryovials are rarely available and plasma is transported in silicate-containing tubes. Some laboratories have questioned if this would affect ACTH concentration as the effect of transferring plasma into silicate-containing tubes has not been evaluated. Whole blood was collected into EDTA tubes from 16 horses ranging from 12 to 17 years of age (9 PPID-positive with endogenous plasma ACTH concentration > 35 pg/mL and 7 PPD-negative). After centrifugation, plasma was aliquoted to either cryovials or silicate-containing tubes.

Samples were stored at 4 C and 20 C. ACTH concentrations were measured using a chemiluminescent assay at 1, 24 and 48 hours after sample collection. There was a significant effect of time on plasma ACTH concentrations in PPID-positive horses at 4 C (P = 0.02) and 20 C (P < 0.0001), and in both groups at 20 C (P ≤ 0.0001) with decreasing plasma ACTH concentrations overtime. However, no significant effect of transferring plasma into a silicate-containing tube was detected in either groups. The use of silicate-containing tubes does not alter ACTH stability. In all cases, it is recommended to keep plasma samples at 4 C to be analyzed within 24 hours.

Effects of oral RRR-A-tocopherol on plasma oxidative stress and endocrine markers in healthy horses Vaughn, Sarah 1 , Norton, Natalie A. 2 Wilcoxon signed rank test as appropriate (P < 0.05). Endocrine parameters did not differ significantly between days 1 and 21 in any of the three treatment groups. There was also no effect of RRR-a-tocopherol treatment on dROMS or PAC. This RRR-a-tocopherol dosing regimen did not alter oxidative stress or endocrine parameters in healthy horses, but further study is needed to assess if treatment could have an effect on animals with endocrine disease or increased oxidative stress E14 Lamellar ribosomal protein s6 activation in three forms of experimentally induced equine laminitis Pinnell, Erin F. 1 

Temporal changes in the fecal microbiota and its functional capacity of ponies developing insulin dysregulation Richness and α-diversity were increased at week 9-13 and week 27-29 in ponies on both diets, indicating a seasonal effect. Ponies on diet B showed a significant temporal shift in fecal microbiota composition (cycle 1: R2 9.1; P < 0.001; cycle 2: R2 9.7; P = 0.025), see Fecal microbiota transplantation has been used empirically for decades in equine medicine but evidence-based information on this technique is scarce. This in vitro study aimed to assess the effect of a common fecal pre-transplantation processing method on microbiota composition and viability of the fecal inoculum.

A fresh equine fecal sample was divided in three 300g aliquots, to be processed identically as follows: feces (T 0 ) were mixed with 1 L of lukewarm water and chopped using an immersion blender to obtain a mixture (T 1 ), which was left uncovered during 30 minutes (T 2 ) and filtered through a sieve to obtain a fecal infusion (T 3 ). Samples were taken at different steps of the procedure (T n ) and immediately stored at 4 C < 6 hours until processing. Bacterial 16S rDNA amplicon profiling associated to propidium-monoazide treatment was performed in each of the 12 samples to select living bacteria. Total flora was measured using quantitative PCR analysis. Bacterial community structure, composition and total flora were statistically compared (significance p < 0.05).

No significant differences in ecological indices or abundance of the major bacterial genera were identified for the different steps of fecal processing. Estimated total flora (mean ± SD) in the final fecal infusion was not significantly lower (10.06 ± 0.07 log gene copies/g) than in the original manure (10.29 ± 0.3 log gene copies/g). Results were similar for all three fecal aliquots.

These results suggest that the processing method described in this study is replicable and the resultant fecal inoculum contains live bacteria and a microbial population similar to the original fecal sample.

Machine learning for the analysis of the fecal microbiota in horses with colitis Ayoub, Cosette 1 , Arroyo, Luis G. 2 The objective of this study was to profile and compare the fecal microbiota of healthy horses (H; n = 50) and those with colitis (C; n = 58). Horses with colitis were further subdivided into survivors (C-S; n = 29) and non-survivors (C-NS; n = 29); as well as those which developed laminitis (C-L; n = 15) and those which did not (C-NL; n = 43). The fecal microbiota was profiled using next generation sequencing. Alpha-and beta-diversity were measured and compared between groups. Three supervised machine learning algorithms including random forest (RF), support vector machine (SVM), and neural networks (NNW) were used to distinguish H vs, C; C-S vs. C-NS; C-L vs. C-NL. Receiver operator characteristic (ROC) curves were constructed to assess the predictive value of the microbiota profile to differentiate pairs of groups.

Community membership and structure was altered in C compared to H (AMOVA P < 0.001). Community membership was different between C-S and C-NS (AMOVA P < 0.03, but no differences were observed between C-L and C-NL (AMOVA P > 0.05). ROC curve analysis showed that the RF, SVM and NNW models had excellent prediction of colitis (area under the ROC curve = 0.98, 0.96, 0.92, respectively). The RF analysis found Treponema, Fibrobacter and The oral supplement Equine Omega Complete (EOC), containing omega-3 fatty acids and α-tocopherol (vitamin E), may anecdotally reduce gastric ulcer formation in horses. The objectives of this study were to determine if EOC supplementation prevents gastric ulcer formation and increases serum α-tocopherol concentrations in adult horses. Nine Thoroughbred geldings were enrolled, ranging from 5-13 years of age. The study was performed in a prospective randomized block design, repeated in a crossover model. Horses were divided into three groups and administered EOC, omeprazole, or water (control) orally for 28 days. Gastric ulcers were experimentally induced on days 21 through 28 via intermittent feed deprivation, while continuing treatment. Gastroscopies were performed on days 0, 21, and 28 and serum α-tocopherol concentrations were assessed on days 0 and 28.

Data were analyzed using a linear mixed model (fixed effects: block, treatment, time), with significance set at p < 0.05 and 95% confidence intervals (CI) reported for post-hoc contrasts. Gastric ulcers were induced between days 21 and 28 (p =0.0009, CI -2.89 to -0.93), with a significant effect of treatment (p < 0.0001) but not block (p =0.09).

Ulcers were significantly induced in the control group (p =0.002, CI 0.41-1.88) but not the omeprazole group. Gastric ulcer grades increased in EOC-treated horses following ulcer induction; increasing from a median score of 0 (0-2) on day 0 to 3 (2-4) on day 28 (p < 0.0001, CI -2.08 to -0.68). Ulcer grades at day 28 were similar in control and EOC groups. Serum α-tocopherol increased in all experimental groups over time (p =0.0005), with no significant difference between treatment groups (p =0.97). Twenty-eight-day supplementation with EOC did not protect against experimental gastric ulcer formation and failed to increase serum α-tocopherol over other treatment groups. The approved omeprazole formulation in horses prevents experimentally induced gastric ulceration.

Immune cell population in the duodenal mucosal in asthmatic horses These results highlight the lack of standardization for etiological diagnosis of entero-typhlo-colitis and emphasize the importance to investigate other possible etiological pathogens causing colitis. It also demonstrates that the inflammation is not always limited to the colon.

Effect of plasma administration on serum amyloid a in neonatal foals Palmisano, Megan G. 1 foals with failure transfer of immunity (FTPI). This study was conducted using samples from 46 healthy neonatal foals. Foals were divided into 3 groups, adequate TPI (IgG > 800 mg/dL) transfused with hyperimmune plasma for prophylaxis against R. equi (RE group, n = 26), FTPI (IgG < 800 mg/dL) treated with hyperimmune plasma transfusion (FTPI group, n = 13), and a control group of healthy foals with adequate TPI (Control group, IgG > 800 mg/dL) that were not transfused (n = 7). Blood samples were collected before (t0, age: 6h to 19h of age) and after plasma transfusion (t1, age: 27 to 40h) and in healthy foals at time 0 (t0, age: 10h to 24h) and time 1 (t1, age: 32 to 47h). Plasma [SAA] was determined using the Stablelab ® EQ-1 Handheld Reader. The foals were monitored throughout the first month of life for any illness or treatment. Steel-Dwass test was used to assess differences among groups or between time points. The age at t0 and Liver disease is encountered commonly in equine practice and is investigated using a combination of historical, clinical, serum chemistry, ultrasound and histopathological data [1] [2] [3] . Collection and examination of liver biopsy specimens is probably the most reliable means of confirming the presence of liver disease as well as guiding therapeutic choices, offering a prognosis for recovery and monitoring progress [2] . Fibrosis is the single most concerning finding in liver biopsy specimens and is a useful prognostic marker [2] . Although historical safety concerns appear to have receded in recent years [4] , biopsy is still a relatively underused methodology perhaps due to lack of clinical familiarity and also financial constraints in many cases. Studies in human patients have revealed several proxy markers for hepatic fibrosis measured in blood samples including hyaluronic acid (HA), type IV collagen 7S, platelet count, aspartate aminotransferase (AST)to-alanine aminotransferase (ALT) ratio, and different scores obtained from algorithms based on these markers and the age, gender, levels of haptoglobin, α₂-macroglobulin, apolipoprotein A1, γ-glutamyl transpeptidase (GGT), bilirubin and/or cholesterol [5] [6] [7] [8] . This study aimed to examine the usefulness of a combination test known as the Enhanced Liver Fibrosis (ELF) test based on measurement of 3 serum analytes comprising HA, amino-terminal propeptide of type III procollagen (PIIINP) and tissue inhibitor of metalloproteinase

Three groups of equids were included in the study. Groups H and D consisted of 10 horses and ponies (group H) and 10 donkeys (group D) that were found to have increased liver-derived serum enzymes and were subject to percutaneous liver biopsy. Group C consisted of 9 horses and ponies that had serum biochemistry testing performed for various clinical concerns and were found to have values for GGT, GLDH, AST and bile acids all to be within the laboratory reference intervals. All serum samples were promptly frozen at -20 C until assay on an ADVIA Centaur analyser (Siemens Healthineers Ltd, Camberley, UK). All samples were analyzed for concentrations of HA, PIIINP and TIMP-1. Measured values were compared between categories of group and also histopathologic fibrosis score [2] using the Mann-Whitney test, and the correlation between variables was tested using Spearman's productmoment test. PIIINP and ELF2 score were not significantly different between groups H and C. However, when all horses and ponies (groups H and C) were considered together and categorized according to histopathologic fibrosis score, HA, PIIINP and ELF2 scores were significantly greater in individuals with a fibrosis score > 2 compared with those with a fibrosis score < 2 (HA p < 0.001; PIIINP p = 0.04; ELF2 p < 0.001) (Fig.1 ). There were no significant differences observed with the data obtained from the donkeys with greater or lesser fibrosis scores. A significant correlation was found between fibrosis score and HA (r = 0,54, p = 0.02), PIIINP (r = 0.46, p = 0.05) and ELF2 score (r = 0.60, p = 0.006) for horses and ponies in groups C and H combined (Fig 2) . No correlation was found in the data from the donkeys. This is the first study investigating HA, PIIINP and ELF scores as diagnostic markers associated with liver fibrosis in horses, ponies, and donkeys. HA, PIIINP and the modified ELF2 score could be useful for prediction and monitoring of liver fibrosis in horses and ponies with elevated liver enzymes and functional parameters as an alternative to liver biopsy. EHV-1 titers increased after D0 only in vaccinated horses (VH) and

were higher than control horses (CH) on D42 and D229. EHV-4 titers shared similar results but did not reach significance.

After in vitro stimulation, VH had greater expression of IFNγ and TNFα on D21, IL-1β on D42, and IL-6 and IL-10 on D21 and D42 than CH. VH had greater CD4 expression but did not reach significance.

Perforin, granzyme B, CD8, IL-2, and IL-18 expression after stimulation did not differ between groups. VH increased and/or maintained D0 IFNγ, IL-6, IL-1β, and TNFα expression. VH maintained D0 IL-10 expression through D42 before decreasing. CH decreased and/or maintained D0 IL-6, IL-10, IL-1β, and TNFα expression but IFNγ expression increased from D0 for D111-D229.

immune responses. Additional research is needed to explore these findings.

First single-cell gene expression analysis of equine bronchoalveolar cells Sage, Sophie E. 1 , Nicholson, Pamela 2 , Peters, Laureen M. 3 , Leeb, Tosso 4 , Gerber, Vinzenz 5 , Jagannathan, Vidhya 4 We profiled 5,078 cells, with a median of 722 genes/cell. Unsupervised graph-based clustering identified 9 distinct cell clusters, grouped into 6 major cell types. Cluster 2 represented monocytesmacrophages based on CD163, APOE, MARCO and CD68 expression.

A subpopulation of cluster 2 with highly expressed MHC-II genes (DRA, DRQ) but no CD163 expression was assigned to dendritic cells. should become notifiable and actionable. Veterinarians who already reported strangles cases were 87% more likely (P = 0.054) to want increased reporting, as did veterinarians who ranked strangles as "very important" or "important" relative to other infectious diseases (OR 3.77, P = 0.037). Veterinarians practicing in the southwest (P = 0.01) and west (P = 0.04) were significantly less likely than northeast practitioners to rank strangles of higher importance. Opinions on equine strangles and desire for increased reporting were varied in the sampled veterinary community. 

Streptococcus equi subspecies equi (S. equi) to prevent spread or false diagnosis of the disease. The purpose of the study was to evaluate the efficacy of manual high-level disinfection between two commonly used disinfectants, 0.6% ortho-phthalaldehyde (OPA) versus 2% accelerated hydrogen peroxide (H 2 O 2 ) following endoscope contamination with standardized S. equi brain heart infusion (BHI) broth. Samples were collected for quantification S. equi real-time polymerase chain reaction (qPCR) and culture before and after disinfection. Endoscope disinfection using OPA (12 minutes), H 2 O 2 (8 minutes), or water as a control (8 minutes) was performed according to manufacturer guidelines following standard enzymatic cleaning. Endoscopes were contaminated and disinfected 30 times for each group with a randomized block design (15 disinfections performed per day for 6 days). Personnel performing culture and qPCR were blinded to treatment. Using multivariable logistic regression model with endoscope and day as random effects, the risk of an endoscope being qPCR-positive following disinfection was determined. 

Effect of bi-weekly administration of diclazuril on antibody kinetics to Sarcocystis neurona in healthy horses population. The horses were randomly assigned to either a treatment or a control group. Treatment consisted in the administration of 0.5 mg/kg body weight of diclazuril pelleted top dress (Protazil) twice weekly (Monday and Thursday of every week) for 12 months. Prior to initiation of treatment and monthly thereafter, blood was collected for the detection of antibodies to S. neurona using an indirect fluorescence antibody test (SarcoFluor). Further, trough plasma diclazuril levels were determined every 60 days.

All 20 horses remained healthy during the entire study period. Seroprevalence (horses with titers ≥ 40) to S. neurona was similar between treatment and control groups at study commencement. Seroprevalence to S. neurona decreased initially in the treatment group to 30% at 30 days post-treatment commencement. This was followed by a slow increase in seroprevalence in the treatment group before reaching 100% in both groups by 90 days post-treatment commencement. The seroprevalence remained 100% in both groups from 90 to 360 study days. While titer distribution between the two groups was similar at study commencement, treated horses displayed significantly lower titers throughout the 12-month treatment period (P < 0.05). All treated study horses had detectable plasma trough diclazuril levels at the six time points and the levels were above the concentration known to inhibit S. neurona in vitro (0.01 μg/mL).

In conclusion, the administration of low-dose diclazuril (Protazil) pelleted top dress twice weekly was able to maintain lower titers to S. neurona in healthy adult horses naturally exposed to the protozoal parasite compared to untreated controls. Further, trough diclazuril levels were in excess of the minimal concentration known to inhibit S. neurona.

A prospective study of serum amyloid a in relation to plasma administration in neonatal foals Eight of the foals were clinically ill prior to plasma administration, and 23 foals were clinically normal. The mean SAA at birth was 1 μg/mL, rose to 11 μg/mL at hour 12, and at hour 13 (post-plasma) was 155 μg/mL. At hour 13, 15/23 (65%) of normal foals and 5/8 (63%) of sick foals had an SAA value >100 μg/mL. Following coccygeal epidural and sedation, a 1.1m flexible endoscope with a 2mm diameter working channel was passed into the bladder through the vulva in a mare or through a perineal urethrostomy in geldings, the ureterovesical junction was identified, a guide wire was passed through the working channel of the scope into the distal ureter. The endoscope was then slid over the wire under continuous saline flush until the ureteral stone was identified. The wire was exchanged for a lithotripsy probe. Stone fragments were flushed and larger fragments withdrawn using forceps passed through the scope.

Two horses underwent EH (one procedure in total for each patient) and the last one laser lithotripsy (three successive procedures in total). Azotemia improved in 2 patients. All patients were discharged from the hospital.

UO in horses can be successfully treated in a minimally invasive manner by lithotripsy. EH lithotripsy proved superior for stone fragmentation. There were no significant correlations using a Pearson correlation coefficient between pituitary and brain measurements, between pituitary measurements and body weight, and brain measurements and body weight. There was no statistical difference using an unpaired ttest (p >0.05) in pituitary and brain measurements between necropsied and non-necropsied horses. All pituitaries were isointense to brain white matter on T1-weighted images. A focal T1 hyperintensity was present in the caudal aspect of the pituitary on pre-contrast T1-weighted images in 88% of horses. In conclusion, pituitary dimensions did not correlate with brain size and body weight or pituitary and brain size in horses. These findings provide a reference for MRI evaluation of the equine pituitary gland. The purpose of this study was to determine if daily intravenous administration of gentamicin for 7 days would affect auditory and vestibular function in healthy adult horses. Ten horses clinically healthy based on physical and neurological examination were selected. Gentamicin sulfate (6.6 mg/kg) was administered in the jugular vein alternating sides for 7 days. Renal function was assessed, and serum creatinine concentrations remained within reference range. Brainstem auditory evoked response (BAER) testing was performed under sedation (IV detomidine hydrochloride 0.01 to 0.02 mg/kg) prior to first, after last dose, and 28 days after last dose. Peaks latencies, amplitudes, and amplitude ratios were recorded. First BAER was used as baseline and compared with results from days 7 and 28. Bone conduction was performed to rule out a conduction disorder. All horses had normal BAER prior to the first dose of gentamicin administration. Seventy percent of the horses had auditory loss: complete bilateral (N = 1), complete unilateral (N = 2), and partial unilateral (N = 4). Auditory loss was based on complete absence of identifiable peaks, increased peak latency, and decreased peak amplitude. Recent advances in near-continuous interstitial glucose monitoring allow for minimally invasive sample collection, reducing stress and discomfort to patients. The objectives of this study were to: 1) to determine the accuracy of two glucose monitoring systems (GMS) for use in horses compared to a point-of-care glucometer (POC) and a standard laboratory enzymatic chemistry method (CHEM), and 2) to determine the accuracy of the devices during dextrose-induced hyperglycemia using an oral glucose absorption test (OGAT). We hypothesized that GMS would provide acceptable agreement with POC and CHEM and provide detailed OGAT glucose curves. Eight clinically healthy adult horses were enrolled in the study. One of each GMS device (Dexcom G6 and Freestyle Libre 14-day) were placed on each horse and blood glucose was measured via POC and CHEM at 33 time points and compared to simultaneous GMS readings. OGAT was performed on day 2 with glucose determination following intragastric administration of 1g/kg 20% dextrose solution. Glucose concentrations were significantly correlated with one another between all devices on days 1-5. Acceptable agreement was observed between Dexcom G6 and Freestyle Libre 14-day when compared with CHEM on days 1, 3, 4, and 5 with a combined mean bias of 10.45 mg/dL and 1.53 mg/dL, respectively.

During dextrose induced hyperglycemia on day 2, mean bias values for Dexcom G6 and Freestyle Libre 14-day showed good agreement (10.49 mg/dL and 0.34mg/dL, respectively). Data supports the use of the Dexcom G6 and Freestyle Libre 14-day interstitial glucose monitoring systems to estimate blood glucose concentrations in horses.

Type of metabolic acidosis and its association with survival in critically Ill horses Gonzalez Carballo, Jose R. 1 ≥ 1 mEq/l); lactic acidosis (LA; L-lactate accounted for > 50% of SBE); unmeasured strong ions (USI) acidosis (USI accounted for > 50% of SBE); and hyperchloremic acidosis (SBE < -2 mEq/l not explained by L-lactate or USI). Mortality was analyzed with logistic regression models with the type of MA (independent variable), and age, disease group, sex, and breed as covariables, and their two-way interactions with MA. The prevalence of MA (pH < 7.32) was 32% (hyperchloremic acidosis: 11%; LA: 17.5%; USI 3.5%) and the overall mortality was 30%.

The odds of dying were greater in horses diagnosed with LA than in horses with hyperchloremic acidosis (OR: 3.29, 95% CI: 1.21 -8.93, P = 0.02) or horses without acidosis (OR: 1.90, 95% CI: 1.02 -3.56, P = 0.04). Differences between other MA categories were not statistically different.

Metabolic acidosis caused by lactic acid appears to be associated with a worse prognosis when compared with horses with hyperchloremic acidosis or horses with normal pH. were noted on electrocardiographic parameters, cardiac rhythm, or NIBP. Diaphoresis was the most common side effect, noted in 6/6 horses following PO and 3/6 horses following IV administration.

Based on this study, intravenous and oral administration of metoprolol tartrate appear to be safe in healthy adult horses. The doses used in this study achieve plasma concentrations reported to achieve maximal ß-blockade in humans.

Pharmacokinetics of thiamine hydrochloride (vitamin B1) in horses after administration of three single intravenous doses Taylor, Sandra 2 , Anderson, Melinda J. 3 , Jannasch, Amber S. 4 Thiamine hydrochloride (HCl) has been used as adjunctive treatment for several conditions in the horse, including neurological and renal diseases, but specific therapeutic effects have not been determined.

In addition, an appropriate dose of thiamine HCl for use in horses has not been established. The purpose of this study was to evaluate the single dose pharmacokinetic profile of thiamine HCl in healthy adult horses after administration at three IV doses.

A randomized cross-over study was done with a one-week washout period between each of three dosages. Nine adult horses from a university teaching herd were administered 5, 10 and 20 mg/kg thiamine HCl IV with dosages chosen based on extrapolation from large animal case reports and human sepsis studies. Heparinized blood samples were collected immediately prior to drug administration and serially over the following 48 hours. Plasma drug concentrations were quantified by high performance liquid chromatography and mass spectrometry. Non-compartmental pharmacokinetic analysis was performed for each dosage level. To determine whether thiamine is eliminated in a linear fashion in the horse or is affected by dosage, elimination rate (l z ) and clearance (Cl) were each compared between dosage levels using a repeated-measures ANOVA and Tukey's post hoc test for multiple comparisons.

Concentration-time curves for IV thiamine HCl administration are presented in Figure 1 and pharmacokinetic parameters are presented in Table 1 healthy four to six-week-old Quarter horse foals were randomly assigned to one of three treatment groups: 1) Control (no treatment), 2) Excede ® (ceftiofur crystalline free acid, 6.6 mg/kg IM q96 hr for 2 doses), and 3) azithromycin (10 mg/kg PO q24 hr for 7 doses). Transtracheal wash samples were collected on days 0, 3, 7, and 35, and aerobic bacterial culture was performed using standard methods. A total of 27 bacterial genera belonging to 4 phyla were observed in the TTW samples. Independent of the treatment and collection time point, bacterial species belonged predominantly to Firmicutes phylum, followed by Proteobacteria, Actinobacteria and Bacteroidetes phyla. At the genus level, only 4 genera were present in every experimental condition; Streptococcus (Firmicutes),

(Firmicutes), Rhodococcus (Actinobacteria) and

Actinobacillus (Proteobacteria 

Effect of treatment with excede and azithromycin on the respiratory microbiota of healthy foals

Antimicrobial treatment affects the respiratory microbiota of children and has been associated with detrimental health effects long-term.

However, the effects of antimicrobial treatment on the respiratory microbiome of foals have not been described. The goal of this study was to determine the effects of two antimicrobial agents on the respiratory microbiota of foals. Twenty-four healthy four to six-week-old Reducing inhaled dust particles improves lung function of horses with severe asthma. Soaked hay is commonly used for this purpose by owners, but its efficacy in improving respiratory function has not been documented. The objectives were to measure the effects of soaked hay in horses with severe asthma, and to compare them to those obtained with an alfalfa pellet regimen.

Ten asthmatic horses in exacerbation were housed indoors and fed soaked hay (45-min immersion, n = 5) or pellets (n = 5). Clinical scores were recorded weekly and pulmonary function measured before and after 2, 4 and 6 weeks. Tracheal mucus scores and cytologic evaluation of bronchoalveolar lavage fluid were performed before and after 6 weeks.

Clinical scores decreased in both groups over time (p < 0.005). Compared to exacerbation, lung resistance was significantly lower at 2, 4 and 6 weeks with soaked hay, and at 4 weeks with pellets (p < 0.01).

Mucus scores decreased significantly with soaked hay, while pulmonary neutrophilia decreased significantly only with the pellet regimen (p < 0.05 for both).

Soaked hay improves clinical scores, lung function and mucus scores of horses with severe asthma. The strict protocol for soaking and discarding dried-out hay in this study could however be considered too great an inconvenience in some stables. Response to soaked hay or pellets could also differ if only a few horses in a barn are on a dustreduction program.

The aim of this retrospective study was to describe the clinicopatho- Although whole blood transfusions are frequently performed in goats, crossmatches are rarely performed due to the large variety of blood groups and associated factors in ruminants. Many universities own donor goats of both large and small breeds due to concern for increased reactions when transfusing between breeds. However, as a large breed goat can donate four times more blood than a smaller breed goat, having a majority of large breed donors may be beneficial.

The objective of this study was to determine the difference in rate of agglutination and hemolytic transfusion reactions between goats of similar and varying breeds.

Ten large breed and ten small breed goats, privately and university owned, were enrolled in this study. Blood from each goat was collected via the jugular vein. Two hundred and eighty agglutination and hemolytic crossmatches were performed: 90 large breed donor to large breed recipient (L-L), 90 small breed donor to small breed recipient (S-S), and 100 large breed donor to small breed recipient (L-S).

Grading was performed using a 0 -4 scale, with > 1 considered a reaction. Differences in outcomes were evaluated using χ 2 or Fisher's exact tests and relative risk. P < 0.05 was considered significant.

Agglutination rates for L-L, S-S, and L-S were 6.67%, 15.6%, and 16% respectively. Differences in agglutination reactions between the three groups were insignificant (P = 0.1). Hemolytic reactions for L-L, S-S, and L-S were 57.8%, 26.7%, and 55% respectively. A significant increase in hemolytic reactions for L-L combinations compared to S-S combinations was seen (P < 0.0001) with a relative risk of 2.167. Similarly, a significant increase in hemolytic reactions for L-S combinations compared to S-S combinations was seen (P < 0.0001) with a relative risk of 2.1.

Clinicians should be cautious when transfusing blood from large to small breed goats due to an increased risk of hemolytic reactions and the potential for an acute hemolytic crisis. When clinically practical, blood from small breed goats should be administered. The HESKA Element is a point of care (EPOC) analyzer validated for use with canine, feline, and equine whole blood samples; despite a lack of validation, these analyzers are also frequently utilized for production animal species such as cattle and sheep. However, erythrocytes of the species for which the EPOC is validated have larger volumes than those from cattle and sheep. As such, the current application of this device for calculation of hematocrit (HCT) in these species is unknown. The objective of this study was to compare HCT measured by the EPOC to spun packed cell volumes (PCV) measured using an automated microhematocrit centrifuge (HemataSTAT II).

The medical records of cattle and sheep presented to a veterinary teaching hospital between January 1, 2017 and October 1, 2020 were screened for animals that had simultaneous measurement of HCT by the EPOC and spun PCV. Results from each method were compared using Pearson's correlation, Bland-Altman analysis, and Deming regression. In this retrospective study, the medical records of camels diagnosed with gastrointestinal parasitism were evaluated with respect to presentation, clinical pathology and parasite identification.

Twenty-nine camels met the inclusion criteria. Ages ranged from 3 months to 19 years (mean: 6.1 ± 4.1 years). Common presenting complaints included hyporexia/anorexia (9/29); diarrhea (8/29); and presumptive weight loss (8/29). Common clinical pathology findings Comparisons between groups were performed using a Kruskal-Wallis test. Cox proportional hazard models were constructed to assess associations between potential predictor variables and mortality during hospitalization. A total of 101 calves met the inclusion criteria, of which only 83 calves were categorized for SIRS. Serum Cannabidiol (CBD) use in epilepsy is ever evolving yet drug-drug interaction studies have not been performed in veterinary medicine. The objective of this study was to assess for drug-drug interaction between phenobarbital (PB) and CBD when administered simultaneously.

Nine healthy beagle dogs were included. A three-phase prospective, randomized PK interaction study between CBD and PB was designed.

Phase 1: single dose CBD tolerability and PK (5 mg/kg, 10 mg/kg, 20 mg/kg) followed by two-week chronic dosing. Phase 2: singledose, three-way, cross-over PK of CBD (10 mg/kg), PB (4 mg/kg), or CBD + PB. Phase 3: chronic PB (4 mg/kg for 30 days) followed by single-dose CBD (10 mg/kg) and PK analysis. Adverse events and laboratory findings were recorded throughout.

No significant difference was observed in the CBD PK of dogs receiving CBD alone or in conjunction with single-dose PB or chronic PB. No significant difference was observed in the PB PK of dogs receiving PB alone or with CBD. Mild adverse events were seen in 7/9 dogs during chronic CBD administration consisting of mild gastrointestinal signs in 5 dogs and ALP elevation >2x reference range in 4 dogs. A significant increase in ALP was observed in chronic CBD of phase 1 between Day 0 and Day 14 (P < .001).

No significant PK interactions were found between CBD and PB. Neither dose escalation of CBD nor adjustment of PB is not recommended based on this study. Monitoring of CBD plasma levels and liver values are recommended with chronic CBD use.

Handheld Raman spectroscopy for intraoperative differentiation of normal brain tissue from neoplasia in canine patients The aim of this study was to assess feasibility of use and accuracy of a hand-held, intraoperative Raman spectroscopy device as a neuronavigation aid to accurately detect neoplastic tissue from adjacent normal grey and white matter. Although Raman spectra are complicated fingerprints of cell signature, the relative shift corresponding to lipid and protein content (2845 cm -1 and 2930 cm -1 , respectively) can provide a rapid assessment of whether tissue is normal white or grey matter versus neoplasia for real-time guidance of tumor resection.

Thirteen client owned dogs were initially enrolled in the study. Two were excluded from final analysis due to patient deterioration or lack of neoplastic disease. The diagnoses of the remaining 11 dogs included 6 meningiomas, 2 histiocytic sarcomas, and 3 gliomas. Intraoperatively, interrogated tissues included normal grey and/or white matter and tumor. A total of 5 Raman spectra readings were recorded from the interrogated tissues and samples were submitted for confir- Twelve dogs were identified, all of which were small or toy-breed dogs with trauma-induced injury. Four dogs were tetraplegic with intact pain perception, seven were nonambulatory tetraparetic, and one was ambulatory tetraparetic. Five/8 dogs that were not tetraplegic were more severely affected in the thoracic limbs. Locked facets occurred at C5/6 (n=7) and C6/7 (n=5). Dorsal displacement of the caudal vertebra's cranial articular process was observed in all dogs. Five/12 dogs had coexistent articular process fractures. Five dogs were treated surgically, three by external splinting, three by strict restriction, and one was euthanized prior to treatment. Eight/9 (88.9%) dogs with known follow-up data had successful outcomes, as defined by independent walking without discomfort. Of these outcomes, nonambulatory dogs (n=8) returned to independent walking in a median of four weeks (IQR 1-12; range 1-28).

In conclusion, cervical locked facet injuries should be a differential for small or toy-breed dogs with a history of trauma and a subsequent cervical myelopathy. This particular luxation affects the caudal cervical spine and can be identified on imaging with the presence of dorsal displacement of a cranial articular process at the luxation site. Our small cohort had largely successful outcomes regardless of treatment choice.

Using deep learning to detect spinal cord diseases on thoracolumbar magnetic resonance images of dogs MRI of 500 dogs with and without thoracolumbar spinal cord conditions were collected. All cases with a diagnosis of intervertebral disc extrusion or protrusion were surgically confirmed. 2693 images of 375 dogs (75%) were used for CNN training. CNN was trained with T1and T2-weighted sagittal and transversal images. Each image was manually labelled as control for the pathology shown. To test specificity and sensitivity the images from the other 125 dogs (25%) were used.

Intervertebral disc extrusion was identified on T1 weighted images with an 80% sensitivity and 96% specificity and on T2-weighted images 93% sensitivity and 99% specificity. Intervertebral disc protrusion was diagnosed with a sensitivity of a 100% and specificity of 95.5% on T1-weighted images and sensitivity of 68% and specificity of 96% on T2 weighted images. Sensitivity for ischemic myelopathy or acute non-compressive nucleus pulposus extrusion on T2-weighted images was 62% and specificity 98%.

CNN can be trained to detect common lesions on thoracolumbar magnetic resonance images. Further studies are needed on a bigger cohort of cases to understand its full potential.

Relationship between hearing and cognitive function in senior and geriatric canines The results provide preliminary evidence that the endolymph MRI appearance is altered on the affected side in the majority of the IVS cases. Further studies are needed to evaluate if the degree of changes can be used to provide prognostic information.

The effect of medium-chain triglycerides on brain metabolism and neurotransmitter concentration numerous studies. However, the mechanism of action remains not fully elucidated. The aim of the current study was to investigate the effect of MCTs on the neurotransmitter concentration in the brain.

Eight healthy Beagle dogs were included in a randomized crossover feeding trial. Dogs were fed with a commercial hypoallergenic dog diet (control), which was either supplemented with one dose of MCT (9 % of caloric requirement, 'acute', 2 h) or for two weeks (9 % of caloric requirement, 'chronic', 2 weeks) substitution with MCT-oil. Currently, assessment of corpus callosum (CC) size in dogs is limited to a subjective analysis as there is no quantitative measurement system established. The purpose of this study was to establish a repeatable quantitative methodology with which to assess CC morphology in a population of dogs undergoing brain MRI at a referral hospital. CC measurements were made on midsagittal MR images in 343 dogs using two techniques previously validated in human studies, CC Ratio (CCR) and CC Index (CCI). The intraclass correlations (ICC) for the CCI were excellent for the intraobserver and good for interobserver measurements. The ICC for the CCR were good for the intraobserver and poor for interobserver measurements. Female entire dogs had a significantly smaller CCR and CCI than all other sex and neuter statuses (all P < 0.01, Turkey Post Hoc Test). Using multivariable models, age was non-linearly associated with ratio. Inclusion of age did not change the direction of estimated effects of sex/neuter status. Similar sex-related differences in the size of canine CC were previously reported in a small, postmortem study. In humans, advanced imaging techniques have shown sex-specific differences in CC neural structure and function. Factors such as influence of female sex hormones on white matter development or regression are thought to be playing a role. This is the first study in dogs assessing repeatability and presence of sex differences using 2 relative CC measurements on antemortem MRI studies. Our findings are relevant for future studies concerning abnormalities in canine brain development and degeneration. Inhalation anesthesia was maintained during the entire scanning process (30 minutes), and FDG was injected one hour before the initiation of PET scan. The standard uptake value (SUV) of FDG was obtained for the seven gross structures (whole brain, lung, salivary gland, liver, spleen, mediastinal blood pool, and kidney cortex) as well as for the seven intracranial structures, including the frontal, parietal, temporal, and occipital lobe, cerebellum, brain stem, and caudal colliculus.

The whole brain and the intracranial structures showed significantly lower FDG uptake in dogs with a longer duration of anesthesia, while other gross structures did not.

Our results suggest that the duration of anesthesia should be considered in the evaluation of FDG uptake by the brain. Fecal CP concentrations during hospitalization and post-operative serum cPLI concentrations were significantly increased compared to recheck samples in dogs managed surgically for TL-IVDH, but the majority remained below the upper limit of the respective reference intervals. No significant differences were identified in CP or cPLI concentrations between dogs with or without GI clinical signs. There was no overt evidence that short-term, prophylactic omeprazole treatment reduced evidence of GI or pancreatic inflammation.

Adapting laser interstitial thermal therapy for treatment of intracranial lesions in dogs Mariani, Christopher L. 1 Laser interstitial thermal therapy (LITT) is a minimally invasive surgical intervention permitting thermal ablation of brain tumors in humans.

During LITT, a laser probe is stereotactically introduced through a small skull burr hole into the tumor. Data from a continuously running MRI scanner is converted to real-time temperature data, and software calculates zones of cytotoxicity as the tumor is heated.

The purpose of this study was to adapt a commercially available LITT system for use in dogs with intracranial lesions. Canine cadavers were used to optimize LITT procedures before performance in live dogs.

Volumetric, T1-weighted, MRI studies were obtained, transferred to a neuronavigation system (Curve, Brainlab) and trajectories to intracranial targets were planned. Dogs were fixed to a surgical bed using a However, pelvic limb reflexes may also be reduced in dogs with a T3-L3 myelopathy and concurrent spinal shock, which can lead to clinical confusion. In order to help distinguish between these two localizations, we Being the caregiver of a dog with epilepsy has potentially wideranging negative effects on human physical health (e.g. sleep), mental health (e.g. anxiety) and overall wellbeing (e.g. social relationships, employment, finances). Greater awareness of these negative impacts may engender better support from the veterinary profession for affected caregivers; however, wider support may be required for the worse affected individuals. Cases with EPS were more likely to have a transient or permanent neurologic deficit than those that did not experience EPS (p = 0.005).

The duration of hospitalization was significantly shorter in dogs that did not experience EPS (p < 0.001). Thus, the occurrence of EPS was not related to a previous diagnosis of epilepsy, tumor location, or prophylactic anticonvulsants, but did occur in patients with worsening neurologic signs after surgery and longer hospitalizations. was 0.5Â10 À3 mm 2 /s (range 0.21 -1.03). There was a significant difference between DTI metrics (P < 0.01) where FA was significantly higher, and MD, AD and RD were significantly lower for ROI compared to SCT. For both ROI and SCT, the DTI metrics MD, AD, and RD were significantly lower (P < 0.01) in dogs that did not return to ambulation. In conclusion, although DTI shows promise as a prognostic tool, a standardized method for processing DTI metrics is needed. 

Cancer anorexia cachexia syndrome and associated biomarkers in dogs with lymphoma pro-inflammatory cytokines and hormonal dysregulation. Dogs might also develop CACS with similar negative outcomes.

We adapted human guidelines to diagnose CACS in dogs with lymphoma. We diagnosed CACS if dogs had > 5% weight loss 6 months prior to lymphoma diagnosis, with any three of following: appetite score < 3, muscle condition score < 3, body condition score < 4/9, CRP > 12.0 mg/l, IL-6 > 4.0 pg/ml, hemoglobin < 14 g/dl, or albumin < 3.2 g/dl. We hypothesized that inflammatory cytokines, ghrelin, leptin and survival would differ between dogs with and without CACS and healthy controls.

We included 36 dogs with lymphoma and 17 healthy controls. We In both cats and dogs, the brain had the highest SUV compared to other gross structures. In the brain, the highest SUV was observed in the cerebellum of both cats (SUVmean: 4.90 ± 1.04, SUVmax: 6.04 ± 1.24) and dogs (SUVmean: 3.15 ± 0.57, SUVmax: 3.90 ± 0.74). Especially, cats had significantly higher intracranial uptake in comparison with dogs (P< 0.001). In the digestive system, the SUVs of the duodenum and the jejunum were significantly higher in dogs than those in cats (P< 0.05).

FDG uptakes of the submandibular tip, the tonsils, the neck of the gallbladder, and the caudal colliculus were physiologically increased in cats.

This study demonstrates physiological FDG uptake in normal tissues throughout the body and its differences were interpreted between cats and dogs based on the species-specificity. This study will contribute to improve the accurate diagnosis of cancer patients and help to understand glucose metabolism in both cats and dogs. Early cancer detection saves lives, but cancer in dogs is usually diagnosed when clinical signs have developed, the disease is advanced, and a cure is unlikely. Non-invasive pan-cancer blood tests are being developed for humans and may soon be available for dogs, leveraging recent advances in cancer genomics and sequencing technology. This 'liquid biopsy' testing may address multiple use cases, including cancer screening in a high-risk population; aid in diagnosis (when the clinical presentation is suspicious for cancer); and recurrence monitoring after therapy.

Nationwide quantitative (n=305) and qualitative (n=16) surveys of licensed veterinarians and veterinary oncologists were conducted by Kynetec, focusing on cancer screening, diagnosis, and management in pet dogs, and on clinician attitudes toward a blood-based liquid biopsy test across multiple use cases.

Respondents were evenly distributed nationwide, averaged 20 years in practice, were 64% female, and primarily treated dogs. Healthy controls (n = 9, age = 4.11 ± 2.52 years, weight = 11.09 ± 8.44 kgs, 78 % male and 22 % female dogs, and 44 % sexually intact) and dogs with systemic diseases were enrolled in three different disease groups: malignant tumor (n = 10, age = 9.30 ± 3.37 years, weight = 9.52 ± 6.93 kgs, 50 % male and 50 % female dogs, and 20 % sexually intact); hyperadrenocorticism (n = 6, age = 9.00 ± 2.19 years, weight = 7.31 ± 4.57 kgs, 50 % male and 50 % female dogs, and 17 % sexually intact); and kidney disease (n = 8, age = 11.29 ± 4.50 years, weight = 4.30 ± 2.14 kgs, 50 % male and 50 % female dogs, and 25 % sexually intact).

Dogs were excluded from the study if they were diagnosed with primary skin disease such as atopic dermatitis. Transepidermal water loss It was observed that the mean TEWL value for the axilla region was significantly increased (p < 0.01) in the dogs with malignant tumors while serum claudin-1 concentrations were significantly lower (p < 0.05) compared to the healthy controls. Serum TNF-α levels were also significantly higher (p < 0.05) in the cancer group than in the healthy group. Also, the subgroup of cancer patients who were treated with chemotherapy showed significantly higher serum MCP-1 concentrations (p < 0.05), but lower IL-6 levels (p < 0.05) compared to the dogs who had not undergone chemotherapy. In the CBC panel, basophils were significantly increased (p < 0.05) in the cancer patients compared to the controls although the mean value was within the normal range (0.048 ± 0.069; reference range, 0.00 -0.10 K/μL).

In conclusion, the skin barrier function was significantly decreased in the dogs with malignant tumors compared to the healthy dogs. The possible explanation is that the inflammatory condition and increased oxidative stress in the oncologic patients might result in a disturbed skin barrier. The most significant factor for local recurrence were narrow or contaminated surgical margins [2] . The treatment of choice at this time is still for conventional aggressive surgical intervention and when margins are not feasible to follow with radiation therapy. But there are limited options for difficult anatomic locations or recurrent sarcomas where radiation therapy would not be desirable and new novel approaches to these tumor types should be considered [3] .

Nanoparticles have been extensively researched over the years [4] and are now being used in human and veterinary clinical trials [5] [6] [7] . After 24 hours in culture under normoxia (21%O 2 ) or hypoxia (1%O 2 ), nuclear and cytosolic HIF-1α protein was detected with a western blotting analysis. Immunoreactive bands were quantified and are presented as relative intensities (%) normalized to those of β-actin (cytosol) or PCNA (nucleus). Each bar represents the mean ± SD of three separate experiments. RNA-sequencing (RNA-seq) is an unbiased technique for examining the transcriptome of a tissue, to identify genes that are differentially expressed between tissues. We hypothesised that thyroids from hyperthyroid and euthyroid cats would have a different transcriptome and that differentially expressed genes would offer novel targets for management of feline hyperthyroidism.

In this pilot study, RNA was extracted from four archived feline thyroid glands, obtained with owner consent and ethical approval, either immediately after euthanasia, or during surgical thyroidectomy and frozen at -80 degrees after fixation in RNAlater. Two glands were from euthyroid cats, one from a medically treated hyperthyroid cat, and one from an untreated hyperthyroid cat. After a ribosomal RNA depletion step, a barcoded RNA-seq library was prepared from each sample and the pooled libraries were sequenced on a single lane of a HiSeq4000.

Sequencing reads were mapped to the feline reference genome (FelCat9.0) and bioinformatic differential expression analysis was undertaken using a bespoke pipeline and high-performance computing cluster. Principal component analysis (PCA) revealed that the 2 euthyroid cats clustered together, separately to the two hyperthyroid cats. The treated and untreated hyperthyroid cats were also separated by the PCA. In total, 1068 genes were significantly differently expressed between hyperthyroid and euthyroid cats. Differentially expressed genes included those related to thyroid hormone synthesis (e.g., SLC5A5, PSMP8), general cell growth (e.g., VEGFA, CNTN1), cell activity (e.g., G6PD, SRXN1) and calcium metabolism (e.g., CYP27B1,

This pilot study demonstrates that RNA-seq is feasible in archived feline thyroid glands and has exciting potential to unravel the pathogenesis of feline hyperthyroidism, as well as to reveal new targets for therapy. Saliva is an attractive matrix for noninvasive glucose quantification; however, glucose measurements in the saliva pose challenges. Low salivary glucose levels require sensitive glucose measurement methodologies. We caution against the stability of salivary glucose secondary to rapid degradation by oral bacteria or during storage.

The use of desmopressin acetate to reduce polyuria and polydipsia associated with prednisolone administration When compared to baseline, six out of seven dogs became polydipsic after administration of prednisolone, 0.5mg/kg orally twice daily.

When desmopressin, 5 mcg/dog subcutaneously twice daily was administered to dogs receiving prednisolone, there was a statistically significant decrease in water intake and sodium concentration, and a significant increase in urine specific gravity.

Administration of desmopressin to dogs receiving prednisolone significantly decreased water intake and sodium concentration, and increased urine specific gravity. This suggests that desmopressin ameliorates the most significant side effect of prednisolone noted by owners, but that hyponatremia is an important complication associated with desmopressin use.

Safety and tolerability of OKV-119: A novel exenatide long-term drug-delivery-system in cats Within-day glycemic variability (GV) is a relevant parameter in monitoring humans with diabetes mellitus (DM). A recent study showed that diabetic cats achieving remission had lower GV when compared with cats not achieving remission. Therefore, it may be useful to investigate further the GV in monitoring feline DM. Our study aims at defining a threshold of within-day GV to predict diabetic remission. In addition, the relationship between GV and insulin therapy, diet, home monitoring, concurrent suspected hypersomatotropism (serum IGF-1 >1000 ng/mL), and glycemic control was evaluated. Blood glucose curves (BGCs) were retrospectively reviewed from the database of a single referral center.

BGCs lasting for less than 8 hours and with less than 4 blood glucose measurements were excluded from the evaluation. Glycemic control was assessed using the serum fructosamine concentration and owner's Previous studies using untargeted metabolomics identified differences in serum metabolites between diabetic and control dogs with some similarities to humans with type 1 diabetes. The purpose of this study was to validate results of previous untargeted metabolomic studies, select candidate metabolite biomarkers, and quantify these using targeted metabolomics.

Untargeted metabolomic analysis via liquid chromatography-mass spectrometry (LC-MS) was performed on serum from diabetic (n=15) and control (n=15) dogs. Results from this combined with results from our previously published studies using identical methods (12 diabetic and 12 control dogs) were used to identify metabolites consistently different between groups in all 54 dogs. Thirty-two candidate biomarkers were measured by LC-high resolution MS and compared between diabetic and control groups via multiple linear regression with age and group as co-variates. A p-value adjusted for multiple comparisons of < 0.0032 was considered significant.

Untargeted metabolomics identified multiple persistent differences in serum metabolites in diabetic dogs compared with our previous studies. Using targeted metabolomics, GABA, valine, leucine, isoleucine, and 2-hydroxyisobutyric acid were higher and indoxyl sulfate, n-acetyl-L-aspartic acid, kynurenine, and tauroursodeoxycholic acid were lower in diabetic versus control dogs (P< 0.0032).

In conclusion, targeted metabolomic analysis confirmed quantitative differences in select serum metabolites between diabetic and control dogs. Some metabolite alterations are consistent with those found in humans, including increases in GABA (type 1 diabetes) and branched chain amino acids (type 1 and type 2 diabetes). Future studies to investigate the role of these metabolites in diabetes pathogenesis or early disease markers in dogs are warranted.

Clinical and laboratory findings in dogs with low basal cortisol levels: A retrospective case-control study According to post-ACTH cortisol levels, dogs were divided into two groups: those diagnosed with hypoadrenocorticism (basal and post-ACTH cortisol ≤ 2 microg/dL -HAC group) and those with a basal cortisol ≤ 2 microg/dL and a physiologic post-ACTH cortisol (Non-HAC group). Shapiro-Wilk test was used to assess normality. Age was expressed using mean ± standard deviation (SD). For comparison between groups, independent Samples T-test and Fisher's exact test were used. A p-value of < 0.05 was considered significant. Eighteen healthy medium-to-large breed dogs were enrolled into the study; Median age was 6 years (range, 2 -12 years), and included 10 spayed females and 8 castrated males. The dogs were ≥ 1 year of age, free from any comorbidities, and were not receiving any medications that are suspected to affect cortisol production. Dogs were fitted with a smart collar (PetPace ® ) the night before the experiment at home, which was removed after the last blood collection was completed the next day in hospital. Dogs were randomized into three groups; A: 6 dogs had their blood collected immediately after 6 minutes of physical activity, B: 6 dogs had their blood collected 15 minutes after the physical activity, and C: 6 dogs had their blood collected at the end of the physical activity, and again at 15 minutes later. All samples were processed shortly after collection, stored at -20 o C, and processed together as a batch. There was an interaction between time and treatment (p = 0.02).

Mean baseline and post-drug BG were unaffected by treatment.

Mean post-prandial BG was higher after capromorelin than placebo (108 ± 14 vs. 95 ± 10 mg/dL, respectively; p = 0.009). Mean 48h IG was 98 ± 11 and 90 ± 12 mg/dL during capromorelin and placebo treatment, respectively (p = 0.08).

This study demonstrated that capromorelin interferes with normal glucose control in healthy dogs. Further studies are needed to determine the mechanism and whether capromorelin poses a risk in dogs predisposed to diabetes mellitus. The purpose of this study was to assess glucose control of PZI insulin (ProZinc ® ) given SID in dogs with laboratory-induced diabetes mellitus. The hypothesis was that ProZinc ® will control hyperglycemia and clinical signs in diabetic dogs using a SID posology. Nine wellcontrolled diabetic dogs on twice daily lente insulin (Caninsulin ® ) were transitioned to ProZinc ® as a single morning dose while maintaining their twice daily feeding regimen. The initial ProZinc ® dose of 1U/kg was decreased to 0.4-0.5IU/kg because of asymptomatic hypoglycemia and then increased by 0.05-0.1IU/kg every 5 days as needed. Glucose control was determined by continuous interstitial glucose monitoring, glucometer, urine ketone, and fructosamine measurements. Food and water consumption, bodyweight, clinical observations, and physical exam parameters were used to assess clinical control. This was a non-randomized, non-blinded laboratory study conducted over 56 days.

ProZinc ® insulin showed a clear and dose dependent biphasic glucose lowering effect over 24 hours. Onset of action was 1-2 hrs, with two peaks of activity occurring at 8-10 and 12-14 hrs. Duration of action was 20-22 hrs. At D56 average weight and water consumption was consistent with those at D0; fructosamine was slightly increased. The objective of the study was to evaluate serum zonulin as a biomarker for canine CE using a commercially available ELISA kit ® . A power analysis was performed for sample size calculations using data from humans. Twenty-two client-owned dogs diagnosed with CE were included in the study (IACUC ASAF # 6482, 20-32, C-8-19). All CE dogs presented with at least one of the following gastrointestinal signs for greater than 3 weeks duration: anorexia, hyporexia, dysrexia, vomiting, weight loss or diarrhea. The alpha and beta diversity measurements (including community membership (Jaccard index), and structure (Yue and Clayton index)) were not significantly different between and within the treatment groups at all times (P > 0.05).

In conclusion, the addition of FMT did not change patient outcome as measured by the CCECAI, albumin, C-reactive protein, and cobalamin levels, as well as fecal microbiota diversity and composition, in dogs with IBD in this study. The objective was to determine whether administration of a prokinetic drug (metoclopramide) before CE administration would affect GI transit times (TT) and completeness of a CE study.

Clinically healthy dogs with normal physical examination and no known GI signs were included in a cross-over, blinded, randomized prospective study. 42]) were included. All studies were complete in treatment group, two studies were incomplete in control group. Treatment did not signifi-cantly increase study completion rate (p=0.22). Fat% was a predictive factor for incomplete study, for each unit increase in fat% dogs where 27% more likely to not complete the study (p=0.019). ITT significantly increased with age (p=0.012).

Metoclopramide did not significantly improve study completeness in healthy dogs, neither significantly increase GI TT. Higher fat% was a predictive factor for incomplete study.

Effect of a commercially available synbiotic on mycophenolate mofetil associated diarrhea mg/kg/day). One of the possible mechanisms for MMF induced GI toxicity is GI dysbiosis, but our previous experiment was unable to document that syndrome in healthy beagles. However, in that experiment, all dogs developed a fecal score of ≥ 4 over the course of the study.

The purpose of this study was to supplement 9 additional beagles that were on the same facility diet as the dogs in the previous experiment with the synbiotic (FortiFlora ® SA, Nestlé Purina) while being administered MMF at 10 mg/kg, PO, twice daily. Individuals masked to the objectives of the study applied a score to each dog's feces daily, using a standardized fecal scoring system. In this system, fecal scores of ≥ 4 are considered diarrhea.

In the 28-day study, the dogs administered MMF alone frequently had a fecal score ≥ 4 (68/252). In contrast, the dogs administered MMF with the synbiotic only had a fecal score of 4 detected twice (2/252). The frequency of fecal scores ≥ 4 (P < 0.0001) was statistically different between groups.

These results suggest that the mechanism of diarrhea associated with MMF may involve effects on the gastrointestinal microbiota and support the use of this synbiotic when MMF is used clinically. Three cats were excluded due to subsequent diagnosis of small cell lymphoma (n = 2) or feline infectious peritonitis (n = 1). Three cats did not eat the diet and were excluded from responder/nonresponder analysis. Fifteen cats had full remission of signs (responders) and 18 cats had partial/no response after 6 weeks of exclusive feeding (non-responders).

The fecal microbiome of cats with CE showed decreased a-diversity in terms of genus richness (P = 0.04) and increased b-diversity in terms of Bray-Curtis Dissimilarity (P < 0.001) compared to control cats. The relative abundance of 15 bacterial genera were significantly different been cats with CE and control at the time of diagnosis (P < 0.05). In particular, cats with CE had more fecal Enterococcus and Clostridium compared to control cats at the time of diagnosis. The distribution of several differentially abundant taxa was bimodal in cats with CE, which was explained by the presence or absence of these taxa. For example, the genus Enterococcus was observed only in a subset of cats with CE and none of the control cats.

Shannon's Diversity Index for a-diversity decreased over time in both responders and non-responders (P < 0.05). At the genus level, bdiversity was different between the responders and non-responders at diagnosis (P = 0.004), but not between the 2 groups after dietary intervention (P = 0.35). However, at the family level, non-responders became increasingly dissimilar after dietary intervention (b-diversity, P = 0.012). Thirty-eight genera were associated with dietary response and included 12 of the 15 genera that were significantly different in cats with CE at diagnosis compared to controls.

Univariable logistic regression models showed no significant association between the presence of fecal Clostridia or Enterococcus in cats with CE and referral center, signalment, duration and nature of signs, body condition score, laboratory parameters (albumin, cobalamin, folate, alanine aminotransferase and alkaline phosphatase), results from imaging and intestinal histopathology, and feline chronic enteropathy activity index (FCEAI) (P > 0.081). Although, cats with a FCEAI of 6 or above were more likely to have fecal Enterococcus, this did not reach significance (P = 0.081). No clinicopathologic variables were significantly associated with response to a hydrolyzed diet (P > 0.117).

As with human inflammatory bowel disease studies, our study suggests Enterococcus is associated with the pathogenesis of feline CE. However, further studies are needed to determine the functional significance of the taxa identified in our study, to explain the bimodal microbiome in feline CE, and to determine the underlying cause for the increasing dissimilarity of the fecal microbiota family in nonresponders following intervention with a hydrolyzed diet. For evaluation of the effect of storage conditions on the dysbiosis index, fecal samples from 9 dogs were used to prepare 9 aliquots from each. DNA was extracted immediately from 1 aliquot. Two aliquots were stored for 1 week at each of the following 4 storage conditions: room temperature, 4 C, -20 C, and -80 C; one aliquot with and one without the addition of 95% ethanol. Quantitative PCR assays were performed for total bacteria, Faecalibacterium, Turicibacter, Escherichia coli, Streptococcus, Blautia, Fusobacterium, and Clostridium hiranonis, and the DI was calculated. For evaluation of the effect of storage conditions on the abundance of IgA coated microbiota, fecal samples from another 7 dogs were used to prepare 3 aliquots from each sample. A single cell suspension was prepared from one fresh fecal aliquot for immediate analysis by flow cytometry, a second aliquot was stored at 4 C for one week, and the third was stored at -80 C for one week prior to analysis by flow cytometry. Statistical analysis was performed for the DI and the IgA-coated/non-IgA-coated microbiota ratio for all aliquots with Friedman tests. Significance was set at P < 0.05.

The DI for all aliquots stored at different conditions with and without 95% ethanol for one week revealed no statistically significant differences (P = 0.656) compared to fresh fecal aliquots. The percentage of fecal IgA coated microbiota, the percentage of non-IgA coated microbiota, and the IgA-coated/non-IgA-coated microbiota ratio showed no significant difference (P = 0.486, 0.237, and 0.185, respectively) in aliquots stored at either 4 C or -80 C for 1 week compared to fresh fecal aliquots.

In conclusion, storage of fecal samples at room temperature, 4 C, -20 C, or -80 C, with or without addition of 95% ethanol for one week prior to DNA extraction had no effect on the dysbiosis index. Also, storage of feces at 4 C or -80 C for one week prior to analysis by flow cytometry had no effect on the IgA-coated/non-IgA-coated microbiota ratio. These findings increase the confidence to clinicians in collecting samples and then shipping it to the diagnostic laboratory, both domestic and international. In cats of the AMC group, the fecal microbial composition was significantly different from DOX (p = 0.011, R = 0.109) and CON (p = 0.001, R = 0.188) on the last day of treatment. The number of observed species (p = 0.025) and Chao1 (p = 0.029) were significantly increased in the DOX group compared to the CON group on the last day of treatment. Cats in the AMC group had a significantly higher abundance of Enterobacteriales (p = 0.010) compared to CON on the last day of treatment. On days 120 and 300, cats in the AMC group had a higher abundance of unclassified Collinsella spp (day 120; p = 0.047, day 300; p = 0.022) compared to CON. Cats in the DOX group had a higher abundance of Proteobacteria on days 60 (p = 0.001) and 120 (p = 0.026) and a lower abundance of unclassified Bulleidia spp.

(p = 0.023) on day 300 compared to cats in the CON group.

In conclusion, amoxicillin/clavulanic acid caused microbial shifts with most of them having subsided by 1 month after discontinuation of treatment. Doxycycline did not cause microbial disturbances during its administration, yet significant changes appeared 1 month after withdrawal and persisted for at least 2 months. Only few changes were identified 9 months after antibiotics withdrawal. Further research is required to determine the clinical significance of these antibioticassociated alterations of the fecal microbiota in cats.

Profiling of the fecal microbiome in cats with chronic enteropathies using quantitative PCR Understanding feline gastrointestinal (GI) pH and transit times is necessary for developing and selecting appropriate drug formulations for cats, particularly those administered orally. Dogs are commonly used for preclinical studies for humans, resulting in an abundance of pharmacologic data for the dog, but there is a paucity of data for the cat. Comparative studies using the same methodology in cats and dogs can help to identify interspecies differences and advance our ability to extrapolate drug data between species. Our main study objective was to measure GI pH and transit times in the fasted and fed state in dogs and compare this to data recently obtained in cats using an identical methodology.

Seven healthy, colony-housed dogs were transitioned to the same diet, used in a previous study in cats, for 2.5 weeks prior to study onset. Food was withheld from the dogs for 20 hours prior to oral administration of a continuous pH monitoring capsule and 15 mL of water. Five hours after capsule administration, dogs were meal fed for a period of 1 hour by offering them their daily allowance of food.

Fasted GI pH and transit times were recorded and compared to previously collected feline data using nested t tests.

In In this prospective, in vitro controlled study, 10 units of PC were obtained from blood donors and separated in two bags, one containing 100% plasma and another containing 35% plasma and 65% of a PAS (Plasma-Lyte A). Both bags were stored at 4 C without agitation for 21 days. At days 0, 7, 14 and 21, the samples were analyzed for the presence of swirling, aggregate formation, platelet counts, platelet indices, glucose, lactate, lactate dehydrogenase, PvCO2, PvO2, maximum percent aggregation via light aggregometry, activation percentages using flow cytometry for the measurement of surface P selectin, and for bacterial growth via culture.

Cold stored PC in both PAS and plasma maintained a mean pH > 6.8 

Anticoagulant effects of rivaroxaban, prednisone, alone and in combination, in healthy dogs Sensitivity and specificity of the cards were respectively 89.9-92% and 96.6-100%, depending on the observer.

Dal agglutination cards are a reliable bedside test, although results should be interpreted cautiously in severely anemic patients.

A pilot study of sample tube temperature changes in three simulated 24-hour shipping conditions Temperature measurements of sucrose solutions (0% to 40%) were compared with plasma and whole blood samples in three temperature conditions across six timepoints. Differing tube types were assessed using both immersion and infrared thermometers in two conditions at two timepoints. Absolute temperature differences were averaged in each condition.

Various sucrose solutions and distilled water changed temperatures similar to blood and plasma in conditions tested ranging from best (0.69 + 0.70 C, 30% sucrose vs. plasma) to worst approximation (1.99 + 1.36 C, distilled water vs plasma). The average of all absolute temperature differences between immersion and infrared thermometers was 1.50 C. For shipping container assessment, the average temperatures of all blood tube types at the 24-hour timepoint were -7.30 + 2.84 C, 19.03 + 0.56 C, and 35.20 + 2.29 C for freezer (cold), room temperature (ambient), and outdoor vehicle (hot) incubation conditions, respectively.

Diverse sucrose solutions and water performed similarly to blood and plasma, and thermometer types performed similarly. Major differences in the 24-hour sample temperatures between different simulated shipping conditions indicate the shipping container did not maintain consistent sample temperature. Investigating the effects of these temperature differences on sample analysis results is warranted. (Figure 1 ). The assay using the RBC controls had a mean accuracy of 93% and within run and between run precisions of 2.01% and 5.49%, respectively. The assay using the IgG-conjugated control beads had a mean accuracy of 100% and within run and between run precisions of 1.57% and 2.61%, respectively. The time to perform the assay was on average 2 hours shorter for the beads than the red cell controls.

For method comparison, FC assay and DAT were performed on 18 dogs with IMHA (diagnosed following ACVIM Consensus Statement guidelines) and 14 non-IMHA anemic dogs. The FC assay had an optimal diagnostic threshold of >1.87% IgG+ erythrocytes; FC assay receiver-operator curve AUC was 0.964 (p < 0.001) for IMHA diagnosis and the assay was 89% sensitive and 93% specific for IMHA ( Figure 2 ). Using this threshold, the FC assay properly classified 16/18 IMHA and 13/14 non-IMHA dogs while the DAT classified 13/18 IMHA and 14/14 non-IMHA dogs correctly. Agreement between assays was good (K = 0.63; 95% CI 0.37-0.89).

Immunoglobulin-coated microspheres appear to be acceptable and stable positive controls for anti-erythrocyte immunoglobulin FC assays. The FC assay may be more accurate for diagnosing IMHA than the immunochromatographic DAT. Further studies are warranted to determine if the quantitative metrics of this FC assay, such as % IgG+ erythrocytes or IgG signal intensity, may be useful for evaluating response to therapy or predicting survival in dogs with IMHA. In conclusion, microcytosis was a common finding in this population and was frequently observed in the absence of anemia. The physiological cause underlying this abnormality was often not identified.

Comparison of i-STAT ® point-of-care blood gas parameters between non-anticoagulated and heparinized whole blood in cats NAB samples were immediately analyzed on an i-STAT ® 1 Analyzer followed by the HEP samples (≤ 5 minutes) quantifying iCa, sodium, potassium, glucose, venous pH, bicarbonate and base excess. Agreement was evaluated using intra-class correlation coefficient and Bland-Altman plot; NAB and HEP measurements were compared using paired t-test and percentage bias was evaluated against their respective allowable total error (TEa).

Glucose and iCa concentrations from HEP were significantly lower compared to NAB (percentage bias -0.84% (-0.06 ± 0.09 mmol/L; P = 0.006) and -0.49% (-0.007 ± 0.013 mmol/L; P = 0.022) respectively). No significant difference was identified for other parameters and the intra-class correlation for all parameters was excellent (r = 0.94-0.99; P < 0.001). One sample exceeded human TEa for iCa (defined as 2%).

from HEP samples, the low magnitude of the negative bias is not deemed clinically important. In practice, NAB and HEP samples may be used interchangeably for blood gas parameters, including iCa, on i-STAT ® 1 Analyzer.

Ultrasonographic characteristics of the portal venous system of 37 healthy unsedated student-owned cats: Prospective study These findings reveal that short axis diameter and L/S ratio on CT are promising tools for predicting liver malignancy and that a liver mass with a L/S ratio > 1.23 might be at an increased risk for malignancy.

Using big data to compare single versus paired bile acid testing in dogs Schooley, Elizabeth 1 , Hegarty, Evan 1 , Day, John 1 , Jaffey, Jared 2 1 IDEXX Laboratories Inc., Westbrook, Maine, USA, 2 Midwestern University, Glendale, USA A dynamic bile acids stimulation test is used diagnostically to evaluate liver function by estimating the efficiency of enterohepatic circulation.

Submission of a single bile acids test is a common practice likely due to the practical difficulties associated with collecting both fasted and 2-hour postprandial blood samples. While an increased result on a single test is suggestive of liver dysfunction, there is concern that omitting the second test decreases the sensitivity of the testing. Past evidence for this is based When using the cutoff of 40 μmol/L to define liver dysfunction, 15.5% of dogs were identified as consistent with liver dysfunction if evaluating the preprandial bile acids test alone, while 25.8% were identified as consistent with liver dysfunction when evaluating the postprandial result alone. One limitation of a big data approach is that information about the individual patient, including reason for testing and definitive diagnosis, is unknown. Therefore, these data should be used with caution to determine the utility of a single bile acids test when evaluating for a specific disease process. The results of this study support the findings of previous studies suggesting that paired bile acids tests identify more dogs with potential liver dysfunction than a single bile acids test and that if a single bile acids test is performed, a postprandial result will be above the diagnostic threshold more often than a fasting bile acids result. Results suggest that medical management alone is often highly successful for various EHBO etiologies. Results support that traditional surgical decompression is associated with a higher mortality rate than medical management or ERCP. Table 1 : Mann-Whitney U tests to compare differences in copy numbers between groups and Spearman's Rank Correlations between serum MicroRNAs copy numbers and serum ALT activity, hepatic copper concentration, inflammatory activity, as well as fibrosis stage.

Correlation with other findings (ρ / P-value) Mann-Whitney U tests were used to compare differences in copy numbers between groups. Correlations between serum MiR copy numbers and serum ALT activity, hepatic copper concentration, inflammatory activity, as well as fibrosis stage were assessed using Spearman's rank correlation. Statistical significance was set at P < 0.05.

No significant differences in serum copy numbers were observed between groups for the 3 MiRs evaluated. No significant correlations were found between copy numbers of any of the 3 MiRs and ALT activity, hepatic copper concentration, inflammatory activity, or fibrosis stage (Table 1) .

Circulating serum MiRs 15b,181a, and 150 copy numbers did not differ in this population of dogs with chronic hepatitis compared to healthy controls. Despite promising results from our previous untargeted study of hepatic expression, these subsequent results did not support the utility of these MiRs as serum markers for chronic hepatitis in dogs. The pathogenesis of gallbladder mucoceles is unknown in the dog. It has been proposed that hyperlipidemia could impair gallbladder motility and contribute to gallbladder mucocele formation.

The objective of this study was to compare gallbladder motility in dogs with hyperlipidemia to healthy, control dogs using ultrasonography. We hypothesized that hyperlipidemic dogs will have decreased gallbladder motility, specifically increased fasting gallbladder volume (GBV) and decreased gallbladder ejection fractions at 60 (EF 60 ) and 120 (EF 120 ) minutes compared to controls.

Twenty-six hyperlipidemic and 28 healthy, age-matched control dogs were prospectively enrolled. Hyperlipidemia was defined as hypercholesterolemia (>332 mg/dL) and/or hypertriglyceridemia (>143 mg/dL).

Primary and secondary causes of hyperlipidemia were included. All dogs were fasted for at least 12 hours prior to collection of plasma biochemistry and pre-prandial ultrasound. Ultrasound was performed on dogs in the fasted state as well as 60 and 120 minutes after being fed 10g/kg of Hill's a/d. GBVs and EFs were calculated using the following formulas: GBV = (0.52 x L x W x H)/kg and EF = ((GBV 0 -GBV 60,120 )/GBV 0 ) x 100, respectively. Normal gallbladder motility was defined as EF > 25%. GBV 0 , GBV 60 , GBV 120 , EF 60 and EF 120 were compared between dogs with hyperlipidemia and controls using the Wilcoxon rank sum test. Statistical significance was set to p < 0.05. EF 120 was < 25% in 9 (35%) and 8 (29%) of hyperlipidemic and control dogs, respectively.

Hyperlipidemic dogs have significantly greater fasting and postprandial GBVs than control dogs but similar ejection fractions. Gallbladder contractility is unaltered in hyperlipidemic dogs, but gallbladder volume remains higher in hyperlipidemic dogs even after feeding. This distention could contribute to retention of bile and gallbladder disease. In this subset of cats, the most common features included the presence of a discrete nasopharyngeal (NP) mass (10/10), middle ear soft tissue attenuation (6/10), and frontal sinus soft tissue attenuation (6/10). The NP masses were located caudal near the tympanic bullae in 8 cats (in 2 cats the mass extended cranially in the NP) and cranial near the choanae in 2 cats. In addition to a NP mass, 2 cats had a mass in the caudal nasal cavity. No cats had lysis of the cribriform plate, maxillary bone, or hard palate; 1 cat had severe lysis of the nasal turbinates and orbit. In this subset of dogs, the most common features were frontal sinus soft tissue attenuation (9/12) and a nasal mass (8/12). The most common mass location was in the caudal nasal passage with extension into the NP (6/8). Lysis of the nasal turbinates (11/12); lysis of the orbit, maxilla, or hard palate (10/12); and lysis of the cribriform plate with meningeal enhancement (9/12) was common in dogs. Mass extension into the intracranial cavity was found in 4 dogs.

In conclusion, a nasal mass is a common feature in dogs and cats with nasal cryptococcosis, especially a discrete mass in the NP of cats.

Nasal cryptococcosis in dogs is more destructive in comparison to cats and lysis of the bones of the nasal cavity with intracranial extension is common in dogs. Biopsy of nasal masses in dogs and cats is encouraged to exclude cryptococcosis.

Susceptibility of imipenem-resistant Pseudomonas aeruginosa isolated from canine otitis These results confirm high breed predisposition for brachycephalic types in general and for some individual brachycephalic breeds in particular. These suggest that conformational reforms may need to be considered for some current breeds to reduce negative welfare impacts. The results also provide an evidence base for current clinical management in first opinion practice that can support measures to improve future management protocols. In this study, dogs that had thromboembolic events, acute kidney injury, or congestive heart failure had a higher risk of mortality. Administration of antithrombotics was associated with prolonged survival time. Streptococcus canis were also found with significant frequency. Overall, there was relatively little acquired antimicrobial resistance in the urinary isolates in this large sample, with the notable exception of high fluoroquinolone resistance in Enterococcus faecalis and Streptococcus canis. The prevalence of multi-drug resistance was highest in Escherichia coli (9.7%) due primarily to resistance to multiple (nonpotentiated) beta-lactam antibiotics, however 84% of these MDR isolates remained susceptible to amoxicillin-clavulanate. Using the formula for rational antimicrobial therapy, the most effective empirical antibiotic choice is the medium-importance antibiotic amoxicillinclavulanate. However, when isolates were divided into two groups by bacterial morphology, low-importance amoxicillin was almost as effective as amoxicillin-clavulanate against cocci, and low-importance TMS was almost as effective against bacilli, highlighting the usefulness of in-clinic urinary microscopy in selecting empirical therapy. We also performed a novel population analysis to incorporate antimicrobial importance ratings with susceptibility results, which suggest that where morphology is unknown, TMS is the best first-line empirical choice and amoxicillin the best second-line choice.

Our results support current international and Australian guideline recommendations of TMS or amoxicillin for empirical treatment of sporadic UTIs in dogs and cats. We also show that in-clinic urinary microscopy can greatly improve antibiotic selection, with amoxicillin a superior choice for UTIs caused by cocci and TMS a superior choice for bacilli.

Hand hygiene compliance and antimicrobial-resistant microorganisms on the hands of veterinary healthcare worker This study suggests that discussion of antimicrobial stewardship is more likely to influence the antimicrobial choice than whether to prescribe or not. Interventions may benefit by focusing on appropriate antimicrobial selection rather than overall prescription frequency.

Prevalence of SARS-Cov-2 in domestic cats presenting to a teaching hospital during the COVID-19 pandemic be exacerbated by stress. The primary hypothesis was that cats supplemented with the BL999 containing product would have higher relaxation scores, lower stress markers, and lower FHV-1 clinical scores than cats supplemented with the same product, but without BL999 as a placebo when mild stress was induced by changing the type of housing. This 12-week study enrolled 24 cats with chronic subclinical FHV-1 infection that were randomly divided into two groups. The cats were supplemented with BL999 (group 1) or placebo (group 2) daily. After BL999 was supplemented for 42 days to achieve probable maximal effects, the cats were moved from the individual gang rooms into cages, back into gang rooms, and then back into cages to induce stress over the next 42 days while behavioral, clinical, and biochemical markers were measured. All cats ate a minimum of 75% of both supplements and there was no obvious vomiting or diarrhea. During the stress periods, the cats supplemented with BL999 were significantly less likely to have abnormal serum cortisol concentrations (P = 0.0059) or sneezing (P < 0.00001). During the times cats were housed in cages, those supplemented with BL999 were significantly more likely (P < 0.0001) to reach out to the scorers through the cage bars and were significantly less likely (P < 0.0003) to pace in the cages. The results of the study suggest that BL999 is well tolerated by cats, reduces stress, reduces stress associated problems like activated FHV-1, and increases social interactions between cats and people. were fed isocalorically based on calculated metabolizable energy (ME) values using Atwater factors (9, 4, and 4kcal/g for fat, protein, and carbohydrate, respectively). Body weights were recorded on weekly basis throughout feeding periods and laparoscopic adipose tissue biopsies were collected under anesthesia at the conclusion of each feeding period.

In spite of isocaloric feeding based on calculated ME values, mean body weights at the conclusion of each feeding period were 8.8 kg and 9.3 kg for CON and WD diets, respectively (P = 0.0018) indicating a likely difference in diet digestibility. H&E stained slides of FFPE adipose tissue biopsies revealed differential deposition of fat in response to each diet. Mean adipocyte diameter of omental fat biopsies was 58.6 and 62.5μM for CON and WD, respectively (P < 0.0001). Conversely, this increase in adipocyte diameter was not seen in subcutaneous fat biopsies. Independent of diet, mean adipocyte diameters (60.7 and 65.65 μM) and adipocyte heterogeneity (variance: 177.0 and 302.45 μM 2 ); differed between omental and subcutaneous fat biopsies, respectively (P < 0.0001).

Collectively, these data indicate that differences in macronutrient composition (especially fat and fiber content) may result in differential effects on adipose tissue deposition and maintenance of body weight even if diets are fed isocalorically based on calculated ME. As Atwater factors are used to calculate ME content of diets in both human and canine nutrition, these results indicate that estimating intake requirements based on energy alone may not be adequate in minimizing metabolic risk to an individual. Future studies should aim to characterize these effects further in both the healthy dog model and obese canine veterinary patients in order to maximize progress in attenuating the effects of diet-related disturbances on both human and animal health. The dose range of Fortetropin ® in cats is currently unknown. This study investigated the safety and tolerability of Fortetropin ® in cats.

Twelve purpose-bred cats were single-housed and randomly divided into 3 treatment groups (n = 4 per group), and were treated for 2 weeks with either a placebo (cheese powder, 1 g/day) or Fortetropin ® at 1 or 2 g/day. The placebo group was treated for an additional 2 weeks with Fortetropin ® at a 4 g/day dose.

No adverse events were observed in cats treated with 1 g/day and 2 g/day of Fortetropin ® . A single episode of diarrhea was reported in one placebo treated cat at day 6, and a single episode of vomiting was reported in one Fortetropin ® (4 g/day) treated cat at day 8.

Our data suggest that cats tolerate Fortetropin ® at doses that are three times the therapeutic dose in other species. Further studies are needed on the efficacy of Fortetropin ® in terms of the treatment of muscle atrophy in cats.

Evaluation of blood thiamine concentration in hospitalized dogs with and without critical illness E. coli, capable of trimethylamine production in the gut, had an increased abundance (adjusted p < 0.05) and may be responsible for the increased circulating TMAO levels in B2 and C/D dogs. C.

hiranonis was the key BA converter, with strong but opposite associations with primary and secondary BAs ( -0.94, 0.95, respectively). Secondary BAs appeared to promote the growth of Fusobacterium and

Faecalibacterium, but inhibited that of E. coli. Beta diversity analysis showed significant clustering based on the levels of DI and C.

hiranonis, both of which were associated with alpha diversity. Multivariate analysis revealed significant but weak associations between gut microbiota and several circulating metabolites, including shortchain acylcarnitines and TMAO. In conclusion, our data suggest that gut microbial dysbiosis takes place at the preclinical stage before Congestive HF, and support the hypothesis of an interplay between gut microbiota, gut microbiota-derived metabolites, and MMVD pathophysiological progression. In conclusion, storage of plasma in EDTA alone results in a significant loss of AG as compared to plasma stored with EAH demonstrating the importance of acidification combined with a protease inhibitor in stabilization of the acyl group and maintenance of AG within the sample.

Subjectively, some sample loss occurred between 1 and 3 months regardless of sample storage method. Future studies of appetite regulation involving AG will benefit from effective storage methods.

Diagnostic yield of cystoscopy compared to ultrasonography for evaluating lower urinary tract disorders in dogs A total of 83 cats met the inclusion criteria, of which 24 cats (29%) had significant bacterial growth on QUC. Escherichia coli (21/24; 88%) was the most common bacteria isolated on QUC. Twenty-nine cats had bacteriuria, 49 cats had an active urinary sediment, and 34 cats had an inactive urinary sediment on microscopic examination, of which 79% (23/29 cats), 37% (18/49), and 18% (6/34 cats), respectively, had significant bacterial growth on QUC. Cats with an active urinary sediment were more likely to have significant bacterial growth on QUC than cats with an inactive urinary sediment (P=.049). Thirteen of the 83 cats (16%) cats had LUTS reported at presentation, of which a majority had an active urine sediment (10/13; 77%) and significant bacterial growth in urine (8/13; 62%). Cats with LUTS were significantly more likely to have a positive urine culture than cats without LUTS (P=.008).

In conclusion, cats diagnosed with AKI with either lower urinary tract signs or an active urinary sediment are more likely to have significant bacterial growth in urine. A urine culture is recommended in all cats with AKI, even those cats with an inactive urinary sediment, to assess the need for antibiotic therapy.

Reliability of Crit-Line ® monitors in predicting hematocrit and change in blood volume during canine hemodialysis The primary study objective was to determine the reliability of Crit-Line ® III and IV non-invasive blood volume monitors to correctly estimate canine PCV and therefore their reliability in reflecting changes in relative blood volume during ultrafiltration. A secondary aim was to determine reliability of targeted ultrafiltration rates through the hemodialysis system by comparing them with delivered ultrafiltration rates.

An ex vivo study using the Gambro Phoenix ® X36 platform with expired canine packed red blood cells was performed. Through dilution and ultrafiltration, clinically applicable PCV values (n=140, median 26%, range 8%-50%) were obtained. PCV values were compared to their respective Crit-Line ® hematocrit and showed good agreement based on Bland Altman analysis (Crit-Line ® III bias 1.8%, 95%CI: -2.5 to +6.2%; Crit-Line ® IV bias 1.0%, 95%CI: -3.3 to +5.4%).

Targeted and delivered ultrafiltration rates (UFR, measured in ml/h) were compared. At UFR0, a median of +40ml/h (range +20 to +120ml/h) was added to the simulated patient. Less than targeted volume was removed (median; range) at UFR100 (-60ml/h; +10 to -90ml/ h), UFR200 (-150ml/h; -120 to -210ml/h), UFR300 (-250ml/h; -220 to -280ml/h), and UFR400 (-340ml/h; -320 to -360ml/h), respectively.

Crit-Line ® monitors provide reliable estimates of canine PCV and thus reliable means of estimating change in blood volume during ultrafiltration. Lower ultrafiltration rates may be less accurate, with minimum ultrafiltration potentially adding volume to a patient, an important consideration in ultrafiltration prescriptions for small veterinary patients.

Characterization of the urinary microbiome in miniature schnauzers with calcium oxalate urolithiasis Coffey, Emily 1 , Gomez, Andres 1 , Burton, Erin 1 , Granick, Jennifer 1 , Lulich, Jody 1 , Furrow, Eva 1 1 University of Minnesota, Saint Paul, Minnesota, USA Emerging evidence suggests that urine is not sterile as previously thought, but instead is comprised of diverse microbial communities.

Alterations in the urinary microbiome are associated with several disease states in humans, including calcium oxalate (CaOx) urolithiasis.

The purpose of this study was to characterize and compare the urinary microbiome of dogs with and without CaOx urolithiasis. However, certain bacterial taxa were more abundant in cases than controls. This study population contained two distinct urinary microbiome subtypes that were not explained by known patient or sample variables; the origin of these discrete subtypes remains undetermined. Urethral obstruction is a common condition in cats. In addition to relieving the mechanical obstruction, a variety of medical therapies have been employed to attempt to prevent re-obstruction, which contributes significantly to morbidity and mortality. Prazosin is an alpha-1 adrenergic antagonist that selectively competitively inhibits post-synaptic alpha-1 adrenergic receptors, directly producing vascular smooth muscle relaxation.

Prazosin has been proposed to act as a urethral relaxant via its smooth muscle activity, therein potentially reducing urethral spasm that may be associated with increased risk of re-obstruction. Potential drawbacks of the use of Prazosin in cats include the need to orally medicate a cat, the potential for side effects (notably, hypotension), and added costs. The primary objective of this study was to compare the rate of recurrent urethral obstruction (rUO) in cats treated with Prazosin compared to cats treated without Prazosin.

Clinicians who either always or never gave prazosin for UO were recruited via the ACVIM and ACVECC list serve. Data from cats were enrolled via an electronic survey (Qualtrics) which included demographic data, treatment data, and if the cat developed a rUO either before discharge or within 14 days. A Fisher's exact was used to compare groups, with a p value of < 0.05 considered significant.

Three hundred and nine cats have been enrolled. Sixty-one (19.7%) cats did not receive prazosin, while Two hundred and forty-eight (80.3%) did receive prazosin. Overall, thirty-three cats (10.7%) developed rUO before hospital discharge and 36 cats (11.7%) developed rUO before 14 days. There was no significant different between the groups in the occurrence of rUO before discharge (11.3% with prazosin, 8.2% without Prazosin, p = 0.64) or within 14 days after discharge (14.6% with Prazosin, 17.6% without Prazosin, p = 0.61).

While further enrollment is on-going, there is no apparent benefit to prazosin administration for reduction of incidence of rUO in the immediate hospitalization period or in the 14 days following discharge from the hospital.

Is glucosuria in dogs fed jerky treats associated with excessive intake of soluble phosphorus? reported in cats fed high phosphorus diets (1). We hypothesized that consumption of commercial dried meat treats might result in excessive intake of highly available phosphorus that increases risk of proximal renal tubular injury. Our aim was to measure total and soluble phosphorus content of treats from the same packets as treats recently consumed by dogs with acquired proximal renal tubulopathy.

Total phosphorus (P total ) content of 7 different commercial dried meat treats was determined photometrically after microwave digestion. The amount of highly soluble (after 1 minute in water) phosphorus (P sol1 ) was measured applying the previously published method (2) . The results were related to metabolizable energy (ME) using the method described by the National Research Council (3).

In 6/7 of the tested treats the amount of P total was above the recommended allowance of 750 mg/1000 kcal (3; Table 1 ), in one case 7-fold. In 5/7 samples the amount of highly available P sol1 exceeded the recommended daily intake of phosphorus, in one case 2.5-fold. Consumption of commercial dried meat treats potentially results in excessive intake of highly available phosphorus increasing risk of proximal renal tubular injury. In dogs, high intake of P sol1 can cause disruption of calcium and phosphate homeostasis (4) and adverse effects on the kidneys (5). It is recommended to limit both the overall daily intake and the intake per meal of P sol1 , and so additional intake via treats with high P sol1 content must be taken into account when assessing risk. It is recommended to check both P total and P sol1 intake in dogs with acquired proximal renal tubulopathy.

Centrifugal mononuclear cell collection in dogs: Safety and efficacy of treatment Foster, JD 1 , Reyes, Noe 2 , Wahaus, Tammie 2 Renal ammonia metabolism is critical to maintaining acid-base homeostasis. Inadequate ammonia excretion appears to drive development of metabolic acidosis in people with chronic kidney disease (CKD) and has been correlated with worse clinical outcomes. Metabolic acidosis is also recognized in dogs with CKD. However, urinary ammonia excretion has not been evaluated in healthy dogs or those with disease. The purpose of this study was to generate a reference interval (RI) for canine urine ammonia-to-creatinine ratio (UAC) in a population of healthy adult dogs from a veterinary teaching hospital.

Sixty adult, client-owned dogs were assessed via history, physical examination, serum chemistry, and urinalysis and 12 were excluded.

Urine samples (n=48) were processed and stored at -80 C within four hours of collection. Ammonia and creatinine concentrations were measured using commercially available enzymatic assays. To establish RI for UAC, 2.5% and 97.5% limits were determined using nonparametric methods. The Dixon method was used to detect and exclude outliers. The RI for UAC was 0.16 -23.69 with 90% confidence intervals for lower and upper limits of (0.13 -1.17) and (20.50 -23.75), respectively. General linear models did not detect significant relationships between UAC and serum bicarbonate, sex, weight, or age. Statistical significance was set at P < 0.05 for all analyses.

Having an RI for UAC in a healthy adult dog population will provide a foundation for future research to determine whether alterations in ammonia excretion are associated with specific disease states which may provide prognostic information or guide clinical management strategies.

Nephroureterolithiasis in dog breeds predisposed to calcium oxalate urolithiasis Hoelmer, Alexis 1 , Lulich, Jody P. 1 Nephroureterolithiasis was more common in CaOx risk breed (23%, 58/251; OR = 4.8, 95% CI 1.7 -18.9, P < .001) than mixed breed (6%, 4/68) dogs. Nephroureterolithiasis was also more common in dogs with LUT urolithiasis (41%, 53/130; OR = 13.6, 95% CI 6.3 -33.1, P < .001) than those without (5%, 9/189). In the regression, LUT urolithiasis was the strongest predictor of nephroureterolithiasis (P < .001), followed by increasing age (P < .001) and lower body weight (P = .0071). Differences in nephrolithiasis prevalence between sexes were not significant (P = .77).

In conclusion, nephroureterolithiasis is common in dogs with LUT uroliths, supporting a shared etiology. Unlike with LUT urolithiasis, nephroureterolithiasis has a similar prevalence in male and female dogs. CysC (sensitivity 93.6% and specificity 100%) and UNCR (sensitivity 88.9% and specificity 100%) exhibited higher sensitivity and specificity compared to CREA (sensitivity 11.1% and specificity 100%) and SDMA (sensitivity 55.6% and specificity 100%) in dogs with CKD IRIS stage Ι.

These findings suggest that the use of CysC and UNCR as biomarkers for CKD leads to early detection of kidney dysfunction and damage in dogs compared to CREA and SDMA. Earlier detection might be desirable for initiation reno-protective interventions that slow the progression of kidney disease.

Isolation of urinary extracellular vesicles from healthy cats and cats with chronic kidney disease Lawson, Jack S. 1 originating primarily from the kidney and urinary tract epithelium, contain proteins, mRNAs and microRNAs, and thus they are a potential source of biomarkers. Our aim was to optimise a methodology for isolating feline uEVs and to characterise the uEV population in cats with normal renal function in comparison to cats with normotensive or hypertensive chronic kidney disease (CKD).

In an initial experiment, feline uEVs were isolated from pooled aliquots of frozen urine (4mL) via three different methods: precipitation, precipitation followed by size exclusion chromatography (precipitation + SEC), and ultrafiltration followed by SEC (UF + SEC). EV preparations were characterised using transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA). Protein concentrations of EV preparations were measured by bicinchoninic acid assay. Particle: protein ratio was calculated as a measure of purity and compared between methods using one-way ANOVA (results reported as mean ± standard deviation).

Records from 2 first opinion practices were then searched for cats >9 years old with and without renal azotaemia. Cats with normal renal function (n = 9), cats with normotensive CKD (NT-CKD, n = 10) and cats with hypertensive CKD (HT-CKD, n = 10) were identified. uEVs were isolated from frozen patient urine samples (4mL) via the UF+SEC method. EV concentration (per mL and normalised to urine creatinine concentration) and mean EV diameter were determined using NTA, and groups were compared using the Kruskal-Wallis test (results reported as median [25 th , 75 th percentiles]).

uEV preparations obtained via all three methods contained particles of the expected size and with expected (cup shaped) morphology on TEM. uEV preparations obtained via UF+SEC had a significantly higher mean particle to protein ratio (5.6 Â 10 8 ± 2.7 Â 10 8 ) than preparations obtained via precipitation alone (9.0 Â 10 6 ± 1.9 Â 10 6 ) or precipitation + SEC (4.1 Â 10 7 ± 4.8 Â 10 6 ; P = 0.009). There was no significant difference in uEV concentration per mL between cats with normal renal function (8.1 Â 10 9 [2.8 Â 10 9 , 1.9 Â 10 10 ] particles/mL), NT-CKD (2.1 Â 10 9 [8.3 Â 10 8 , 9.8 Â 10 10 ] particles/mL) and HT-CKD (1.8 Â 10 9 [9.2 Â 10 8 , 5.6 Â 10 9 ] particles/mL; P = 0.26). There remained no significant difference between groups when EV concentration per mL was normalised to urine creatinine (P = 0.68). Mean particle size did not differ between groups (normal In conclusion, feline uEVs can be successfully isolated from frozen urine of cats with and without CKD, with ultrafiltration followed by size exclusion chromatography resulting in the purest uEV preparations. Further work to catalogue the EV proteome may result in the identification of novel therapeutic targets and biomarkers of disease.

Use of telmisartan to address proteinuria in dogs in various clinical contexts: A retrospective study Forty-four client-owned dogs with proteinuria. Retrospective study;

dogs diagnosed with significant proteinuria (non-azotemic dogs with a urine protein creatinine ratio (UPC) value ≥2 and azotemic dogs with a UPC value ≥ 0.5) were separated into 3 groups: telmisartan alone, with benazepril or combined with mycophenolate. UPC values were recorded prior to treatment and at subsequent follow-ups (1, 3, 6 and 12 months when available). Response to treatment was categorized as complete (UPC <0.5), partial (UPC value decreased by ≥ 50% but ≥ 0.5) or no response (UPC value decreased by < 50%). Serum creatinine, potassium and arterial pressure were also recorded.

In the telmisartan group, therapeutic response (UPC <0.5 or value decreased by ≥ 50%) was observed in 70%, 68%, 80% and 60% of individuals at 1, 3-, 6-and 12-months follow-up respectively. A similar trend was observed in the 2 other groups. No significant changes were noted in serum creatinine, potassium, or arterial blood pressure at all follow-up times. Side effects observed were mild self-limiting gastro-intestinal signs for 5 dogs. Two dogs developed significant azotemia that required discontinuation of the treatment prior to the first follow-up.

Telmisartan could be considered for management of proteinuria in dogs in various clinical contexts, alone or in combination with other common treatments for proteinuria. (dark grey bars), partial (UPC ≥50% decrease from baseline but ≥0.5) (light grey bars) and no response (UPC decrease >50% from baseline) (white bars) after receiving telmisartan at 1, 3, 6-and 12-month follow-ups.

An updated relative supersaturation program, EQUIL-HL21, compared to EQUIL93 applied to healthy dogs and cats For this study, the original EQUIL2 BASIC program was embedded into a spreadsheet program so it could be used on modern computers with up-to-date software and will henceforth be referred to as EQUIL-HL21. A comparison between EQUIL-HL21 and EQUIL93 calculated RSS using dog and cat urine was then performed. Urine was obtained from 10 dogs and 10 cats fed the same food for 14 days. On the last day of feeding all urine produced in a 24-hour period was collected by free catch into a closed system and was analyzed for NH 4 These results suggest that bacterial culture of urine should be considered in the diagnostic workup of cats classified as having IRIS stages 2-4 CKD to evaluate the presence of pyelonephritis, and that a negative urine culture may not rule out infection. Since most of the cats did not have sample collection until up to 2 hours after death, there could be concern for bacterial translocation to renal tissues. However, since the cadavers were kept on ice and very few cats were positive for bacterial growth, we believe translocation is an unlikely explanation for the positive samples. The DNA extraction methods to be used in the second objective are being optimized. After optimization, it will be determined by 16S rRNA PCR and next generation sequencing whether there is a renal microbiome in cats > 10 years of age and if there are associations among the results of different bacteria and CKD.

Assessment of capillary rarefaction in cats with and without CKD a key driver of fibrosis in CKD and is associated with capillary rarefaction (reduction in vascular density) in humans. The purpose of this study was to determine if capillary rarefaction occurs in cats with CKD.

Seventy-eight archived formalin-fixed paraffin-embedded kidney tissues collected at autopsy from cats with CKD (16 IRIS Stage 2, 18 IRIS Stage 3, and 24 IRIS Stage 4) and without CKD (10 young cats (≤9 years old) and 10 geriatric cats (≥10 years old)) were assessed.

Percentage glomerulosclerosis, inflammation and fibrosis were scored as absent, mild, moderate or severe. Vascular structures were identified with a combination of CD31 immunohistochemistry and visual assessment. Consecutive high-power fields (40x), ten from the cortex and five from the corticomedullary junction (CMJ) were examined and an observer (masked to clinical data) identified, counted and colored the capillary area. Image analysis of the colored capillaries was used to determine average capillary size, and average % capillary area (capillary area/total area). Differences between cats with and without CKD

were assessed with Kruskal-Wallis test, Mann-Whitney U test, and

Ordinary one-way ANOVA where appropriate. The correlation between capillary size or % capillary area and serum creatinine, % glomerulosclerosis, fibrosis, and inflammation was assessed with Spearman rank.

There was no significant difference in capillary count between cats with and without CKD in the cortex or CMJ. Capillary size was significantly smaller in CKD cats than cats without CKD in both the cortex and CMJ (P = 0.0001 and P = 0.0013 respectively). Percent capillary area was significantly smaller in CKD cats than cats without CKD in both the cortex and CMJ (P = 0.0005 and P = 0.008 respectively). Capillary size in the cortex and CMJ and % capillary area in the cortex were negatively There was no correlation between % capillary area in the CMJ with fibrosis and inflammation within the CMJ.

Capillary rarefaction was observed in cats with CKD and was associated with severity of disease. Further exploration of novel treatments directed towards ameliorating capillary rarefaction is warranted.

Effect of dietary protein concentration on serum concentrations of gut-derived uremic toxins in healthy cats The major gut-derived uremic toxins indoxyl sulfate (IS), p-cresol sulfate (pCS), and trimethylamine-n-oxide (TMAO) are metabolites of bacterial protein fermentation in the colon of cats. In people and dogs, a low protein diet reduced serum concentrations of one or more of these uremic toxins. The objective of the study was to determine the effect of a low protein diet in comparison to a high protein diet on the serum IS, pCS, and TMAO concentrations in healthy cats.

Twenty healthy 3-year-old mixed sex research-bred cats were enrolled in a prospective randomized controlled diet trial. Cats were fed a commercial cat food for at least 3 months prior to enrollment (protein 34% dry matter [DM] ). For study purposes, low protein (LPD) and high protein (HPD) dry diets were formulated to be as similar to one another as possible except for protein concentration (LPD, 31% DM; HPD, 45% DM). Cats were randomized into 2 groups and fed ad libitum either the LPD or HPD for 12 weeks. A fasted serum sample was collected at the same time of day at baseline and 4, 8, and 12 weeks after feeding the study diets. Serum In conclusion, consumption of a HPD can increase serum concentrations of pCS, however the effect may be temporary. A HPD may contribute to the accumulation of IS in the serum of healthy cats. Serum 12 of 22 sample (55%) were positive for growth from the microbiology laboratory. Overall sensitivity and specificity was 73% and 91% respectively (95% CI: 46-99; 73-100). The sensitivity and specificity was 0% and 91% (95% CI=0=0; 73-100) for < 1,000CFU/mL and 80% and 91% when ≥1,000CFU/mL (95% CI=55-100;74-100). For gram negative positive RIA tests, gram negative bacteria were correctly identified in 5/5 of samples. No association was seen between RIA status and level of pyuria (P = 0.09) or hematuria (P = 0.61). While our preliminary data had a higher prevalence of positive cultures compared to previous larger studies,the RIA had lower sensitivity but similar specificity. Further samples are needed to determine the accuracy of RIA for < 1,000 CFU positive urine cultures and to assess the accuracy of the RIA for correctly identifying gram negative bacteria. Similarly, CKD progression was faster in the B2 subgroup than in the CKD group (worsening from IRIS stage 1 to 2 [P = 0.002]; occurrence of isosthenuria [P = 0.003]); however, there was no significant difference between the B1 subgroup and the CKD group.

The results of this study suggest that stage B2 MMVD could be a risk factor for the progression of CKD. Furthermore, our findings may help to predict the prognosis of dogs with both CKD and MMVD and provide insight into the proposed mechanism of cardiovascular-renal disease.

Rectal thermometers (RT) are routinely used to assess body temperature (BT) in dogs and cats, but this method is often a source of significant stress for the animal. Non-contact infra-red thermometers (NCIT) have gained popularity during the SARS-COV2 pandemic as a rapid non-invasive method for assessing BT. The aim of this prospective, multi-centre observational study was to compare the agreement of standard rectal temperature with temperature measured with NCIT in a population of dogs and cats.

NCIT readings were taken in triplicate, using a PC868 Infrared Thermometer (Shenzhen Pacom Medical Instruments Co. Ltd.). from the hairless skin on the medial aspect of the pinna. RT was then taken using a standard digital thermometer. Ambient room temperature, signalment, presence of icterus, skin and coat colour, reason for presentation and final diagnosis (if known) were recorded. Patients were classified as normothermic if their BT (determined by RT) was within reference interval (38 -39.2 C), hyperthermic if BT was > 39.2 C and hypothermic if BT was < 38 C. Performance of the NCIT was determined by assessing both correlation (using Kendall'tau) and agreement (using Kappa analysis, and Bland-Altman plots).

One hundred and fifty-nine dogs and sixty-three cats were recruited. In The purpose of this study is to identify the effects of early-age ovariohysterectomy performed at 6 weeks and 8 weeks on body weight, some blood and physiological parameters and behavior in female kittens. 20 clinically healthy kittens were randomly allocated into two groups as Group I (neutered at 6 weeks, n=10) and Group II (neutered at 8 weeks, n=10). All kittens in groups were neutered by midline ovariohysterectomy under general anesthesia. Incision was made in the middle third and then both ovaries and cornu uteri were removed. Blood analyses (complete blood count, glucose, BUN, creatinin, calcium, phosphorus), physiological parameters (heart rate, respiratory rate, body temperature) and behavior (general activity, aggression, interest in humans and other kittens) were evaluated starting from one week before surgery until two weeks following the surgery.

During the study period, no significant differences were observed on body weight and, physiological and behavioral parameters in both groups. Although group I kittens were higher body weight compared to group II, body weight increase in both groups were similar during the study. The serum concentrations of glucose, BUN, creatinine, calcium, phosphorus and complete blood counts in each group were within reference ranges and no significant changes were observed throughout the study.

In conclusion, data obtained from this preliminary study revealed that body weight, blood and physiological parameters as well as behavior were similarly affected in both groups of kittens performed early-age ovariohysterectomy. Early-age ovariohysterectomy does not affect body weight, some blood and physiological profiles as well as behavior negatively. This study was a prospective study. A total of 206 cats diagnosed using various tests were included; 128 cases with acute inflammation and 78 cases without acute inflammation.

In the comparison of each disease group to the group without any disease, a significant increase of the SAA concentration was found in the infectious, respiratory, gastrointestinal, and urogenital disease groups (P < 0.05). No significant differences were observed among the disease groups.

A significant correlation was found between SAA concentration and white blood cell and neutrophil counts (P < 0.0001). In the comparison of acute inflammation cases with non-acute inflammation cases for each marker, a significantly strong correlation was found for SAA (P < 0.0001, sensitivity, 66%; specificity, 78%), and a significant correlation was found for white blood cell count (P = 0.026, sensitivity, 43%; specificity, 75%) and neutrophil count (P = 0.036, sensitivity, 44%; specificity, 72%).

As a marker of acute inflammation, SAA has a higher sensitivity and specificity than white blood cell and neutrophil counts. Therefore, SAA can be a useful inflammatory marker for the diagnosis of acute inflammation.

Developing an end-of-life survey to capture cause of death and reasons for euthanasia in dogs Here we describe EOLS development, qualitative assessment, and preliminary results. EOLS was created by a veterinary internist, veterinary resident, veterinary epidemiologist, and human epidemiologist. Item domains include cause of death, observed changes associated with aging or illness, perimortem veterinary care, quality of life assessment, and reasons for euthanasia. Items were optimized for clarity and comprehensiveness through several pilots with 42 total bereaved dog owners. The final survey was evaluated for accuracy and consistency by conducting verbal participant interviews with 28 bereaved dog owners before survey completion and comparing to subsequent survey responses to confirm reliability.

Among interviewees, the most common causes of death were cancer (n=9; 33%), weakness secondary to old age (n=4; 15%), and kidney disease (n=3; 11%). Euthanasia was performed in most dogs (n=23; 85%), and the most common reason for euthanasia was poor quality of life (n=12; 52%). However, average quality of life in the two weeks prior to death was more commonly reported as good than bad (n=16; 59%). We have demonstrated EOLS is an objective instrument capable of accurately capturing detailed information from owners about companion dog death. This instrument will be deployed in the DAP longitudinal study of aging to elucidate cause of death as well as other important factors such as reasons for euthanasia and quality of life assessment.

Development and reliability of a survey instrument used to create a canine multimorbidity index A well-recognized prognostic indicator in human medicine is multimorbidity, which is defined as the co-occurrence of two or more chronic conditions. As such, physicians and researchers have developed numerous multimorbidity indices to improve their prediction of patient prognosis which enables them to identify interventional targets, prioritize treatment options, determine treatment efficacy, anticipate patient needs, and develop comprehensive health policies. No such index exists for veterinary patients. Here we report the development and reliability of a novel Canine Multimorbidity Index (CMI), which was modeled after current human multimorbidity indices and adapted for use in canine patients. The index was created by a veterinary internist, veterinary epidemiologist, and human health epidemiologist. Pilot studies to assess reliability by comparing inter-and intra-rater agreement were conducted with primary care veterinarians who utilized the instrument to score multimorbidities in selected canine medical records. The initial pilot revealed substantial intra-rater agreement (kappa = 0.69) but poor inter-rater agreement (kappa = 0.34). Verbal feedback from pilot testers indicated lack of clarity surrounding disease definitions (e.g., what duration constitutes "chronic" gastrointestinal disease?) and uncertainty of diagnosis requirements (e.g., is thoracic imaging required to diagnose chronic bronchitis?). The instrument was modified by adding specific definitions for indexed diseases and offering response variables that encompassed presumptive and definitive diagnoses. A pilot of the updated instrument is ongoing, and following pilot testing, multimorbidity data from a long-term longitudinal cohort, the Dog Aging Project, will be collected in order to assess CMI's ability to predict canine prognosis, namely mortality and clinical outcomes. 

Influence of Feeding on IL-2 expression and peak blood concentration in dogs administered oral cyclosporine Pan, Marianne 1 , Archer, Todd 2 , Mackin, Andrew 2 , Summers, Stacie 1 , Narayanan, Lakshmi 2 , Woodruff, Kimberly 2 , Gordon, Jana 1 1 Oregon State University, Corvallis, Oregon, USA, 2 Mississippi State University, Starkville, USA Cyclosporine A (CsA), a calcineurin inhibitor used to treat numerous diseases in dogs, blunts interleukin-2 (IL-2) expression in activated T lymphocytes. A previous study has shown a decrease in oral bioavailability when CsA is administered with food in dogs, leading to the recommendation to give CsA when fasted. However, in practice, CsA is often administered with food to reduce gastrointestinal side effects. The objectives of this study were to compare the pharmacodynamic and pharmacokinetic effects of oral CsA when administered with and without food, and to determine whether its administration with food decreases gastrointestinal side effects in healthy dogs.

In a randomized, open-label, crossover design, 5 healthy dogs received oral modified cyclosporine (Atopica; median dose rate 3.5 mg/kg; range 3.4 -3.9 mg/kg) with food for 7 days or one hour before food for 7 days (or vice versa), separated by a 21-day washout period. Peak respectively. An additional adverse gastrointestinal side effect (vomiting) was seen once in each treatment group. There was no significant difference in appetite (P = 0.338) and fecal consistency (P = -0.8052) scores between dogs that were fed or fasted at the time of drug administration.

In conclusion, in healthy dogs, modified cyclosporine can be administered with food without affecting its pharmacodynamic or pharmacokinetic profile, and can achieve levels of IL-2 expression that correspond to adequate immunosuppression. However, the administration of cyclosporine with food may not reduce gastrointestinal side effects. More than 90% of the CBR-1 gene sequences have been analyzed.

We found two sets of mutations in the canine model. First, a silent mutation C.20543C >T was identified in 2 dogs located within the region of the X2 exon. Second, a novel 128 bp insertion was found in intron 1 at C.7623. This is the first report of an intronic CBR-1 mutation due to a short interspersed element insertion, and it is necessary to validate this insertion mutation at the RNA level. Characterization of this mutation's impact on transcription and protein translation is necessary to fully understand its influence on receptor function. Further studies are necessary to determine whether the variation in clinical outcomes associated with CBD treatment can be attributed to this genetic variation. In the future, we hope to see that genetic variation within the endocannabinoid system is utilized when forming a treatment plan for a patient. Our results suggest that generic modified cyclosporine may be an acceptable substitute for the proprietary product in dogs. Use of generic modified cyclosporine can represent a significant cost saving for owners.

Effect of inhaled albuterol on whole blood potassium concentrations in dogs Ogrodny, Andrzej J. 1 , Jaffey, Jared A. 2 , Acierno, Mark 2 , Costa, Renata 2 , da Cunha, Anderson 2 , Jones, Teela 2 , Kreisler, Rachael 2 , Westerback, Emily 2 1 Department of Small Animal Clinical Sciences, Midwestern University, Glendale, Arizona, USA, 2 Department of Pathology and Population Medicine, Midwestern University, Glendale, USA Inhaled albuterol is a common intervention used to treat moderateto-severe hyperkalemia in humans; however, its effect on blood potassium concentrations in dogs has not been investigated.

This study had two objectives: (1) to determine if inhaled albuterol decreases blood potassium concentrations in dogs and if a difference in effect exists dependent upon albuterol dose, and (2) to assess if inhaled albuterol effects heart rate or blood glucose concentrations because tachycardia and hyperglycemia can occur in humans. Pharmaceutical grade albuterol sulfate (90 μg/actuation) was administered to normokalemic dogs via "AeroDawg" chamber device at a low-dose (90 μg) in Phase I and high-dose (450 μg) in Phase II executed seven days later. Whole blood potassium and glucose concentrations as well as heart rates were obtained at baseline and at 3, 5, 10, 15, 30, 60, 90, 120, 180, and 360 minutes (min) after the tenth breath following inhaler actuation. Whole blood potassium and glucose concentrations were measured on a blood gas analyzer. The nadir of the potassium concentrations for each dose was compared to its baseline using a two-tailed paired t-test, while sign rank tests were used to compare the peak heart rate and glucose concentrations to their respective baselines. Linear regression clustered by dog was used to determine the response based on dose. P ≤ 0.05 was significant. Ten dogs were enrolled in this crossover clinical trial. The median low-dose delivered Itraconazole (ITZ) is a commonly used azole antifungal in dogs. The major plasma metabolite of ITZ, hydroxy-ITZ, is generated by the hepatic cytochrome P450 (CYP) enzyme system, but the specific isoform(s) responsible is unknown. Understanding species-specific metabolism of this drug is important in predicting toxicity as well as potential drug-drug interactions. Therefore, the purpose of this study was to identify the CYP enzyme(s) that hydroxylates ITZ in canine liver. Reaction conditions for hydroxy-ITZ generation were first optimized by incubating ITZ with dog liver microsomes. Then, ITZ was incubated with recombinant canine CYP enzymes (CYP1A1, CYP1A2, CYP1B1, CYP2B11, CYP2C21, CYP2C41, CYP2D15, CYP3A12, and CYP3A26) and Michaelis-Menten kinetics for ITZ hydroxylation were established for each. After incubation with ITZ, the following recombinant enzymes produced hydroxy-ITZ: CYP1A1, CYP1B1, CYP2B11, CYP2C41, CYP2D15, and CYP3A12. However, after correction for relative expression within canine liver microsomes, CYP2D15 and CYP3A12 appear to be the isoforms quantitatively important for ITZ hydroxylation. These isoforms also had k m values (5.95 mM and 4.36 mM, respectively) most similar to the k m in dog liver microsomes (5.43 mM). Therefore, CYP2D15 and CYP3A12 should be considered the top candidate enzymes for conversion of ITZ to hydroxy-ITZ in dog liver. Confirmatory studies using CYP isoform-specific inhibitors are currently underway. about CBD considered its administration safe in a wide range of low or high doses in healthy animals, and is currently studied for its analgesic and antiepileptic effects in some canine chronic conditions. The delta-9-tetrahydrocannabinol (THC) is the main psychotropic phytocannabinoid, and is commonly found in a limited range of concentrations (< 1%) in several pharmaceutical preparations in conjunction with CBD. Although accidental exposure to high doses of THC is known to cause neurologic signs and depression in dogs, safety studies of dogs exposed to preparations with a THC:CBD ratio 1:20 reported few adverse effects in low doses (0.1 mg/kg). Veterinary prescription of CBD with low concentrations of THC (< 0,2%) is currently legal in Colombia. Although many dogs are increasingly being prescribed with phytocannabinoid compounds, no information exists about anesthetic considerations in elective surgical and anesthetic procedures. The objective of this study is retrospectively review the effect of a single dose administration of two pharmaceutical grade CBD oils on basic cardiorespiratory parameters and anesthetic recovery of dogs undergoing elective surgery. Complete medical and anesthesia records of healthy dogs of the spay/neuter program of Corporaciòn Universitaria Santa Rosa de Cabal UNISARC whose owners approved a preoperative single dose of CBD were included for analysis. Dogs were considered clinically healthy based on physical examination, complete hemogram and serum creatinine and ALT concentration. Two types of CBD oils were used, a full spectrum cannabis oil with 200 mg/ml and THC up to 1 mg/ml (THC:CBD 1:20 ratio from Clever Leaves, Colombia) and a THC Free CBD oil with only 100 mg/ml (CBD only formula of Neviot ® , Procaps Colombia).

Cannabidiol dose used was 2 mg/kg, the amount of product was calculated based on CBD concentration and randomly applied to dogs orally, 1 hour before any anesthetic premedication and closely monitored. Dogs then were routinely pre-medicated with standard care analgesia with meloxicam, tramadol and sedation with xylazine, after 20 minutes were induced and maintained with ether ketamine and/or propofol according to individual needs. Basic monitoring of heart rate, respiratory rate, pulse, rectal temperature was used during surgery and in recovery period. Once awake post-surgical pain was graded using the Glasgow Composite Pain Scale (GCPS) and any adverse effects or any other reaction was documented. Average heart rate, respiratory rate and temperature during surgery was calculated and compared between CBD and CBD:THC 20:1 doses using independent samples T test analysis for normal distributed variables and Mann-Whitney U test for nonparametric variables. Any adverse effect, anesthetic complication was documented. After retrospective analysis, 20 owners of dogs approved the CBD administration, 4 medical records were incomplete and excluded from the analysis and 16 dogs were included. There were 11 females and only 3 male dogs with a median age of 4,4 years (range 0,5-9 years). None of the dogs experience adverse effects during the first hour of observation. According to the type of CBD used, 7/16 animals received the THC:CBD ratio 1:20, no anesthesia complication was observed during surgery. In 9/16 dogs a CBD without THC was administered, only one dog experienced epileptiform activity during anesthetic induction. Average heart rate of dogs during surgery was not significantly different between CBD preparations (p = 0,39), also average temperature (p = 0,52) and respiratory rate (p = 0,056) during surgery was not statistically different between groups. During recovery 2 dogs in CBD:

THC group show mild ataxia and only 1 dog in the CBD group. average pain GCPS scores were not statistically different between groups (p = 0,32). All dogs recovered well and discharged the same day and no one experienced moderate or severe adverse events. In this retrospective study a preoperative single oral administration of 2 mg/kg of Cannabidiol (CBD) oil in dogs was not associated with severe adverse effects. Some dogs experienced mild ataxia during recovery and no differences were observed between heart rate, respiratory rate and temperature between groups of CBD oils. The oil of THC:CBD with ratio of 1:20 was well tolerated in dogs receiving < 0,1 mg/Kg of THC. There was no difference between pain post-surgical pain scores between CBD oils.

Comparing nasal sampling techniques for culture and mycoplasma polymerase chain reaction in canine nasal disease Sixty-seven client-owned dogs with HH.

Medical records of dogs with HH presenting to the veterinary teaching hospitals at Auburn University and University of Missouri between 1/1/2009-12/31/2020 were retrospectively reviewed. Between group comparisons were made by Mann-Whitney Rank Sum test (P < 0.05).

Dogs with HH presented with exclusively respiratory (17/67), mixed respiratory and GI (22/67), or GI signs alone (28/67). While brachycephalic dogs were not significantly more likely to present with respiratory clinical signs (P=0.145), they were statistically younger (P< 0.001), more likely to present in respiratory distress (P=0.023), and with radiographic evidence of aspiration pneumonia (P< 0.001) compared to non-brachycephalic dogs. Normal thoracic radiographs were noted in 5/12 dogs with clinical signs of respiratory disease. HH was detected by thoracic radiography in 54% of cases versus 95% by VFSS.

Dogs with HH may present with exclusively with respiratory signs.

Respiratory signs may be more severe in brachycephalic compared to non-brachycephalic dogs. VFSS is superior to thoracic radiographs for the detection of HH in dogs.

Distribution of allergens in cats with feline asthma: Clinical Experience in Ankara, Turkey

Keskin Yılmaz, Nevra 1 , Kahraman, Duygu 1,3 , Albasan, Hasan 2 1 Faculty of Veterinary Medicine, Department of Internal Medicine, Ankara University, Ankara, Turkey, Ankara, Ankara, Turkey, 2 Pet Depot Veterinary Group, La Verne, CA 91750, USA, Los Angeles, USA, 3 Arbor Vitae Veterinary Clinic, Ankara, Turkey Feline asthma (FA), a common serious lower respiratory system disease, is triggered by multiple aeroallergens and is driven by the stimulation of T helper 2 (TH2) response 1,2. TH2 mediated immunity results in increased production of cytokines that regulate the allergic inflammatory response and immunoglobulin E (IgE) production, leading to airway remodeling and obstruction1,2.

The aim of present study was to identify retrospectively the most prevalent allergens in cats with FA presented from 2017 to 2020.

Study materials were consisted of 14 indoor cats diagnosed with asthma. Of 14 cats; 7 were female (1 intact and 6 spayed) and 7 were male (5 intact and 2 neutered). The mean age of cats at the time of diagnosis was 3.5 years old ranged from 6 months to 8 years. In vitro veterinary Polycheck allergy test was used to detect allergen-specific In summary, HDMAs seem to be the significant potential sources of sensitization that are underpinning the asthmatic response in cats.

Therefore, dust free home environment can be the most important contributing factor in prevention and treatment of asthma disease in cats. Mechanical testing was performed on cylindrical stents produced in the same manner and with identical wall thicknesses to the patientspecific stents in compression platens in accordance with standards defined by the American Society for Testing and Materials. These results were compared to commercially available stents currently used in the treatment of nasopharyngeal stenosis.

Stent placement was successful in all dogs and aided by modifications to the stent design during the development process. Goodness of stent fit varied among dogs. The stent in the smallest dog (7kg) was oversized causing in-folding of the stent.

The 3D-printed stents exhibited comparable stiffness and force required for compression compared to commercial stents, and also showed the least post-load deformation.

Production and placement of 3D-printed patient-specific nasopharyngeal stents is feasible and these stents offer comparable mechanical properties to commercial stents. Future studies in live animals are indicated.

Effect of a high phosphorus diet on indicators of renal health in cats

A pilot study on in vitro solubility of phosphorus from mineral sources, feed ingredients and compound feed for pigs, poultry, dogs and cats

Effects of dietary phosphates from organic and inorganic sources on parameters of phosphorus homeostasis in healthy adult dogs

Potassium hydrogen phosphate induced nephropathy in the dog. II. Glomerular alterations

Advances in the understanding of pathogenesis, and diagnostics and therapeutics for feline allergic asthma

Feline Asthma: Diagnostic and Treatment Update

Buhl, Rikke 1 , Hesselkilde, Eva M. 2 , Carstensen, Helena 2 , Hopster-Iversen, Charlotte 2 , van Loon, Gunther 3 , Decloedt, Annelies 3 , van Steenkiste, Glenn 3 , Marr, Celia M. 4 , Reef, Virginia B. 5 , Schwarzwald, Colin C. 6 , Mitchell, Katharyn J. 6 , Nostell, Katarina 7 , Nogradi, Nora 8 , Saxmose, Søren 2 , Carlson, Jonas 9 , Platonov, Pyotr G. 9